data_2cez_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2cez _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 CA--C 1.552 1.03 0 N-CA-C 112.406 0.521 . . . . 0.0 112.406 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -143.96 102.73 3.93 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.68 1.192 . . . . 0.0 111.926 -174.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -70.45 -18.58 75.47 Favored Glycine 0 N--CA 1.477 1.376 0 C-N-CA 124.418 1.009 . . . . 0.0 114.517 -179.324 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.0 t -72.03 -16.28 18.5 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.184 0 C-N-CA 124.882 1.273 . . . . 0.0 112.008 173.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 96.34 40.94 3.82 Favored Glycine 0 CA--C 1.534 1.277 0 C-N-CA 124.414 1.007 . . . . 0.0 113.535 -175.526 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 . . . . . 0 N--CA 1.477 0.918 0 C-N-CA 125.767 1.627 . . . . 0.0 111.724 -177.49 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 30.8 p-90 . . . . . 0 CA--C 1.543 0.674 0 CA-C-O 120.89 0.376 . . . . 0.0 111.832 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 5.3 mtmt -149.97 22.89 0.87 Allowed 'General case' 0 CA--C 1.557 1.222 0 C-N-CA 128.011 2.525 . . . . 0.0 111.1 -176.178 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 21.4 mt-10 -52.13 140.95 19.66 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 124.357 1.063 . . . . 0.0 113.485 -169.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 67.9 m-80 -76.84 -25.89 53.7 Favored 'General case' 0 CA--C 1.545 0.758 0 N-CA-C 113.55 0.944 . . . . 0.0 113.55 -173.331 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 27.6 m -73.52 151.85 89.55 Favored Pre-proline 0 CA--C 1.547 0.859 0 C-N-CA 123.92 0.888 . . . . 0.0 112.465 176.656 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -73.77 -18.1 22.34 Favored 'Trans proline' 0 CA--C 1.539 0.766 0 C-N-CA 122.988 2.459 . . . . 0.0 112.703 169.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 53.35 14.17 0.51 Allowed 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 129.67 3.188 . . . . 0.0 116.43 173.443 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 74.32 38.45 0.53 Allowed 'General case' 0 CA--C 1.552 1.055 0 C-N-CA 129.099 2.96 . . . . 0.0 112.908 178.741 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 36.2 t -57.31 -33.73 44.33 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 C-N-CA 124.372 1.069 . . . . 0.0 112.435 172.25 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 10.8 t . . . . . 0 C--O 1.255 1.378 0 C-N-CA 125.144 1.378 . . . . 0.0 113.32 179.809 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 84.1 mttt . . . . . 0 N--CA 1.48 1.057 0 CA-C-O 121.872 0.844 . . . . 0.0 112.66 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -62.78 -26.77 68.88 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 125.421 1.488 . . . . 0.0 114.718 -172.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 77.74 -46.12 2.55 Favored Glycine 0 N--CA 1.478 1.455 0 C-N-CA 125.564 1.554 . . . . 0.0 114.031 176.417 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 4.1 m -60.7 -30.52 47.17 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.296 0 C-N-CA 125.032 1.333 . . . . 0.0 114.089 175.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 132.61 24.85 0.73 Allowed Glycine 0 N--CA 1.476 1.336 0 C-N-CA 125.503 1.525 . . . . 0.0 115.63 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 11.8 mt-30 . . . . . 0 N--CA 1.479 0.978 0 C-N-CA 125.697 1.599 . . . . 0.0 111.616 -179.291 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 38.3 p-90 . . . . . 0 CA--C 1.543 0.675 0 N-CA-C 111.794 0.294 . . . . 0.0 111.794 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 6.0 mtmt -151.77 22.53 0.69 Allowed 'General case' 0 CA--C 1.556 1.173 0 C-N-CA 127.746 2.419 . . . . 0.0 111.672 -174.173 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 21.4 mt-10 -51.54 141.03 16.88 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 124.268 1.027 . . . . 0.0 113.753 -169.149 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 68.3 m-80 -81.85 -21.95 37.25 Favored 'General case' 0 CA--C 1.546 0.801 0 N-CA-C 113.625 0.972 . . . . 0.0 113.625 -174.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 22.8 m -71.86 152.76 93.16 Favored Pre-proline 0 N--CA 1.475 0.784 0 O-C-N 121.174 -0.954 . . . . 0.0 112.578 176.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -74.06 -17.59 21.99 Favored 'Trans proline' 0 CA--C 1.539 0.764 0 C-N-CA 123.002 2.468 . . . . 0.0 112.441 169.663 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 53.19 13.92 0.45 Allowed 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 129.664 3.186 . . . . 0.0 116.371 174.428 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 74.79 35.15 0.66 Allowed 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 129.136 2.974 . . . . 0.0 113.121 178.613 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 28.0 t -51.26 -44.06 29.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 C-N-CA 124.474 1.11 . . . . 0.0 111.646 174.057 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 5.6 t . . . . . 0 C--O 1.254 1.313 0 C-N-CA 127.273 2.229 . . . . 0.0 112.887 172.775 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 14.4 tmtt? . . . . . 0 N--CA 1.474 0.747 0 CA-C-O 121.208 0.527 . . . . 0.0 110.291 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -89.96 139.31 30.73 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 125.173 1.389 . . . . 0.0 111.227 173.658 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -79.13 43.26 2.45 Favored Glycine 0 N--CA 1.476 1.306 0 C-N-CA 125.167 1.365 . . . . 0.0 114.602 -176.078 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 5.6 p -168.83 -50.41 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.262 0 C-N-CA 125.566 1.547 . . . . 0.0 112.657 -177.481 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 145.54 52.6 0.03 OUTLIER Glycine 0 N--CA 1.477 1.392 0 C-N-CA 124.417 1.008 . . . . 0.0 114.906 -178.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 31.6 mt-30 . . . . . 0 N--CA 1.48 1.04 0 C-N-CA 126.049 1.74 . . . . 0.0 112.85 176.212 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 34.3 p-90 . . . . . 0 CA--C 1.545 0.757 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 6.8 mtmt -146.91 24.52 1.18 Allowed 'General case' 0 CA--C 1.555 1.17 0 C-N-CA 128.067 2.547 . . . . 0.0 110.877 -175.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -54.6 139.0 39.79 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 124.048 0.939 . . . . 0.0 112.497 -169.259 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 9.4 p30 -149.44 17.37 0.92 Allowed 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 124.54 1.136 . . . . 0.0 113.405 -171.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 18.6 m -70.22 154.63 94.4 Favored Pre-proline 0 CA--C 1.549 0.926 0 C-N-CA 125.1 1.36 . . . . 0.0 113.497 -175.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -73.75 -14.66 24.32 Favored 'Trans proline' 0 C--N 1.356 0.922 0 C-N-CA 123.618 2.879 . . . . 0.0 113.372 171.206 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . 0.275 1.8 pp 58.87 4.45 0.4 Allowed 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 130.368 3.467 . . . . 0.0 117.039 169.555 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 29.2 m120 77.5 47.0 0.06 Allowed 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 129.8 3.24 . . . . 0.0 111.789 177.224 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 56.0 t -62.93 -29.57 47.49 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.213 0 C-N-CA 124.361 1.065 . . . . 0.0 111.402 169.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 11.7 p . . . . . 0 C--O 1.253 1.275 0 C-N-CA 126.194 1.798 . . . . 0.0 114.654 175.6 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 54.0 mtmt . . . . . 0 CA--C 1.544 0.728 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -13.97 96.25 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 128.987 2.915 . . . . 0.0 115.244 -169.602 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -67.26 -28.18 73.65 Favored Glycine 0 N--CA 1.479 1.524 0 C-N-CA 123.847 0.737 . . . . 0.0 113.796 -171.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.8 m -61.41 -27.56 42.18 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.158 0 C-N-CA 125.157 1.383 . . . . 0.0 113.286 169.542 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 137.63 123.91 2.24 Favored Glycine 0 CA--C 1.528 0.871 0 C-N-CA 128.011 2.719 . . . . 0.0 109.36 -172.648 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 32.9 mt-30 . . . . . 0 N--CA 1.473 0.687 0 C-N-CA 125.293 1.437 . . . . 0.0 111.145 171.677 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . 0.499 ' CZ3' ' HE2' ' A' ' 11' ' ' LYS . 30.2 p-90 . . . . . 0 CA--C 1.542 0.66 0 N-CA-C 114.242 1.201 . . . . 0.0 114.242 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.499 ' HE2' ' CZ3' ' A' ' 10' ' ' TRP . 27.9 mtmt -145.3 -62.05 0.34 Allowed 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 126.457 1.903 . . . . 0.0 109.034 176.512 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 62.54 171.71 0.14 Allowed 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 128.751 2.82 . . . . 0.0 113.191 178.291 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 69.0 m-80 -112.31 0.87 15.85 Favored 'General case' 0 CA--C 1.549 0.918 0 N-CA-C 114.034 1.124 . . . . 0.0 114.034 -176.244 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 15.8 m -69.76 150.19 96.62 Favored Pre-proline 0 N--CA 1.475 0.823 0 O-C-N 120.712 -1.243 . . . . 0.0 113.614 -175.711 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -76.34 -16.19 17.47 Favored 'Trans proline' 0 CA--C 1.541 0.83 0 C-N-CA 123.33 2.687 . . . . 0.0 112.136 169.383 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 54.17 14.35 0.72 Allowed 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 129.69 3.196 . . . . 0.0 116.498 175.038 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 78.77 33.25 0.27 Allowed 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 129.343 3.057 . . . . 0.0 113.235 172.486 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 47.3 t -56.5 -32.57 36.84 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.381 0 C-N-CA 124.745 1.218 . . . . 0.0 112.251 175.152 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 77.7 p . . . . . 0 C--O 1.253 1.239 0 C-N-CA 125.935 1.694 . . . . 0.0 113.468 179.425 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 4.4 tmtm? . . . . . 0 N--CA 1.48 1.065 0 N-CA-C 112.209 0.448 . . . . 0.0 112.209 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -169.8 151.75 4.3 Favored 'General case' 0 N--CA 1.481 1.075 0 C-N-CA 127.138 2.175 . . . . 0.0 111.232 -179.368 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -155.1 -46.8 0.02 OUTLIER Glycine 0 N--CA 1.479 1.518 0 C-N-CA 124.984 1.278 . . . . 0.0 114.643 -179.591 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.4 t -41.48 -56.49 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 C-N-CA 126.812 2.045 . . . . 0.0 113.379 177.109 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -140.52 -18.0 0.41 Allowed Glycine 0 N--CA 1.477 1.393 0 C-N-CA 124.244 0.926 . . . . 0.0 115.382 177.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 99.1 mt-30 . . . . . 0 CA--C 1.545 0.773 0 C-N-CA 125.821 1.648 . . . . 0.0 113.368 177.103 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 49.3 p-90 . . . . . 0 CA--C 1.546 0.794 0 CA-C-O 121.519 0.676 . . . . 0.0 112.776 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 22.1 mtmt -115.22 -23.78 8.79 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 127.196 2.198 . . . . 0.0 111.252 175.108 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 19.26 -88.76 0.0 OUTLIER 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 131.32 3.848 . . . . 0.0 114.623 -175.142 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 69.1 m-80 -130.28 23.27 5.19 Favored 'General case' 0 CA--C 1.553 1.059 0 C-N-CA 126.933 2.093 . . . . 0.0 111.93 179.294 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 35.3 m -114.93 154.08 47.03 Favored Pre-proline 0 N--CA 1.476 0.837 0 C-N-CA 125.284 1.433 . . . . 0.0 113.251 -169.76 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -78.28 -15.81 14.1 Favored 'Trans proline' 0 CA--C 1.541 0.837 0 C-N-CA 123.311 2.674 . . . . 0.0 112.304 169.288 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 52.25 15.52 0.47 Allowed 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 129.406 3.083 . . . . 0.0 116.38 177.063 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 72.2 26.59 2.72 Favored 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 129.309 3.044 . . . . 0.0 112.715 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 5.3 p -65.75 -25.97 37.7 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.241 0 C-N-CA 124.251 1.02 . . . . 0.0 113.675 -175.091 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 11.2 t . . . . . 0 C--O 1.256 1.419 0 C-N-CA 125.608 1.563 . . . . 0.0 111.63 175.935 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 38.2 pttt . . . . . 0 N--CA 1.481 1.079 0 CA-C-O 119.709 -0.186 . . . . 0.0 111.19 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -155.79 151.08 26.79 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 126.067 1.747 . . . . 0.0 109.989 169.394 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -71.19 -37.09 63.67 Favored Glycine 0 N--CA 1.478 1.483 0 C-N-CA 123.397 0.522 . . . . 0.0 112.59 179.512 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.5 m -64.75 -32.32 57.51 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.223 0 C-N-CA 124.912 1.285 . . . . 0.0 112.99 169.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 133.39 -77.03 0.39 Allowed Glycine 0 N--CA 1.469 0.854 0 C-N-CA 126.576 2.036 . . . . 0.0 111.929 177.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 16.1 mp0 . . . . . 0 CA--C 1.555 1.143 0 C-N-CA 124.918 1.287 . . . . 0.0 112.546 -173.498 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . 0.462 ' CZ3' ' HE2' ' A' ' 11' ' ' LYS . 32.7 p-90 . . . . . 0 CA--C 1.549 0.909 0 CA-C-O 121.619 0.723 . . . . 0.0 112.869 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.462 ' HE2' ' CZ3' ' A' ' 10' ' ' TRP . 14.8 mtmt -46.16 -42.97 14.67 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 127.739 2.416 . . . . 0.0 114.62 -177.638 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 29.89 -99.09 0.01 OUTLIER 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 129.074 2.95 . . . . 0.0 114.134 -170.371 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -162.68 35.3 0.11 Allowed 'General case' 0 CA--C 1.55 0.972 0 C-N-CA 126.642 1.977 . . . . 0.0 111.676 -169.606 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 44.7 m -133.23 152.4 79.41 Favored Pre-proline 0 N--CA 1.478 0.958 0 C-N-CA 124.299 1.04 . . . . 0.0 112.79 -172.528 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -77.94 -16.78 14.14 Favored 'Trans proline' 0 C--N 1.354 0.821 0 C-N-CA 123.556 2.837 . . . . 0.0 112.792 169.783 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 50.62 17.11 0.35 Allowed 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 129.603 3.161 . . . . 0.0 116.54 176.907 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 77.04 32.2 0.49 Allowed 'General case' 0 CA--C 1.551 1.019 0 C-N-CA 129.549 3.14 . . . . 0.0 113.375 174.895 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 42.8 t -56.03 -33.64 36.4 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 C-N-CA 124.513 1.125 . . . . 0.0 112.291 174.26 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 77.5 p . . . . . 0 C--O 1.252 1.233 0 C-N-CA 125.949 1.699 . . . . 0.0 113.372 179.467 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 55.2 tttp . . . . . 0 N--CA 1.476 0.84 0 N-CA-C 112.797 0.666 . . . . 0.0 112.797 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -94.92 -32.31 13.27 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 124.65 1.18 . . . . 0.0 113.481 178.188 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 72.64 19.82 79.33 Favored Glycine 0 CA--C 1.537 1.43 0 C-N-CA 124.127 0.87 . . . . 0.0 114.185 -173.457 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 48.4 t -149.95 -68.64 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 C-N-CA 126.48 1.912 . . . . 0.0 109.21 -172.506 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 158.46 42.21 0.02 OUTLIER Glycine 0 CA--C 1.536 1.353 0 C-N-CA 125.316 1.436 . . . . 0.0 113.41 -178.406 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 40.5 mt-30 . . . . . 0 N--CA 1.479 0.989 0 C-N-CA 126.043 1.737 . . . . 0.0 112.099 -169.751 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . 0.449 ' CZ3' ' HE2' ' A' ' 11' ' ' LYS . 51.0 p-90 . . . . . 0 CA--C 1.545 0.77 0 CA-C-O 120.915 0.388 . . . . 0.0 110.089 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.449 ' HE2' ' CZ3' ' A' ' 10' ' ' TRP . 13.7 mtmt -47.85 -39.99 20.1 Favored 'General case' 0 CA--C 1.552 1.046 0 C-N-CA 126.548 1.939 . . . . 0.0 113.808 178.553 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 19.4 mm-40 46.28 -104.54 0.1 Allowed 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 128.286 2.634 . . . . 0.0 112.016 175.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 5.3 p30 -176.88 -48.84 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 127.842 2.457 . . . . 0.0 110.328 174.212 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 21.2 m 71.92 156.82 0.16 Allowed Pre-proline 0 CA--C 1.551 1.019 0 C-N-CA 127.583 2.353 . . . . 0.0 113.744 172.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -76.86 -22.94 11.26 Favored 'Trans proline' 0 C--N 1.354 0.844 0 C-N-CA 122.926 2.417 . . . . 0.0 112.725 170.111 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 50.3 15.87 0.23 Allowed 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 129.496 3.118 . . . . 0.0 116.815 175.379 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 69.78 41.34 1.21 Allowed 'General case' 0 CA--C 1.553 1.065 0 C-N-CA 128.802 2.841 . . . . 0.0 113.083 -178.562 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 42.5 t -58.35 -33.99 49.11 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 C-N-CA 124.053 0.941 . . . . 0.0 112.356 170.337 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 76.2 p . . . . . 0 C--O 1.255 1.365 0 C-N-CA 126.923 2.089 . . . . 0.0 114.828 178.678 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 24.7 mtpp . . . . . 0 N--CA 1.485 1.303 0 N-CA-C 114.31 1.226 . . . . 0.0 114.31 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . 112.22 -36.6 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.303 1 C-N-CA 132.031 4.132 . . . . 0.0 112.541 -179.066 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 73.48 -55.47 2.01 Favored Glycine 0 CA--C 1.532 1.118 0 C-N-CA 126.386 1.946 . . . . 0.0 112.889 -175.092 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 4.8 p -74.78 -38.16 43.83 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.13 0 C-N-CA 125.584 1.554 . . . . 0.0 113.13 -176.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 170.93 -83.47 0.08 OUTLIER Glycine 0 N--CA 1.47 0.921 0 C-N-CA 124.967 1.27 . . . . 0.0 112.803 -175.74 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 6.4 mt-30 . . . . . 0 N--CA 1.48 1.053 0 C-N-CA 129.098 2.959 . . . . 0.0 109.672 -179.7 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 41.9 p-90 . . . . . 0 CA--C 1.544 0.743 0 N-CA-C 112.229 0.455 . . . . 0.0 112.229 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 4.6 mtmt -147.5 23.32 1.14 Allowed 'General case' 0 CA--C 1.557 1.221 0 C-N-CA 127.991 2.516 . . . . 0.0 111.075 -174.668 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -49.73 139.99 12.13 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 124.703 1.201 . . . . 0.0 113.928 -168.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 11.8 p30 -74.0 -18.24 60.88 Favored 'General case' 0 CA--C 1.547 0.841 0 N-CA-C 113.695 0.998 . . . . 0.0 113.695 -178.75 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 21.2 m -72.27 154.33 92.07 Favored Pre-proline 0 CA--C 1.548 0.892 0 C-N-CA 124.864 1.265 . . . . 0.0 112.915 177.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -75.89 -15.48 18.81 Favored 'Trans proline' 0 CA--C 1.541 0.825 0 C-N-CA 123.445 2.763 . . . . 0.0 112.789 169.66 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 51.94 19.89 1.09 Allowed 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 129.241 3.016 . . . . 0.0 116.204 173.491 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . 0.273 12.0 p30 51.29 37.77 19.63 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 129.278 3.031 . . . . 0.0 113.539 -173.241 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 6.9 p -67.77 -26.78 35.89 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.183 0 N-CA-C 113.309 0.855 . . . . 0.0 113.309 -179.611 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 71.0 m . . . . . 0 C--O 1.252 1.228 0 C-N-CA 126.955 2.102 . . . . 0.0 113.13 176.008 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 19.0 pttp . . . . . 0 N--CA 1.484 1.266 0 N-CA-C 113.077 0.769 . . . . 0.0 113.077 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -139.3 -46.19 0.46 Allowed 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 114.449 1.277 . . . . 0.0 114.449 -171.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 77.34 25.08 64.29 Favored Glycine 0 CA--C 1.54 1.614 0 C-N-CA 123.93 0.776 . . . . 0.0 114.212 -173.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.1 m -156.49 -39.41 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 C-N-CA 126.677 1.991 . . . . 0.0 113.153 -172.748 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 118.46 62.05 0.29 Allowed Glycine 0 N--CA 1.474 1.174 0 C-N-CA 125.077 1.322 . . . . 0.0 112.922 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 37.9 mt-30 . . . . . 0 CA--C 1.553 1.077 0 C-N-CA 125.942 1.697 . . . . 0.0 113.707 176.393 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . 0.487 ' CZ3' ' HE2' ' A' ' 11' ' ' LYS . 46.6 p-90 . . . . . 0 CA--C 1.547 0.827 0 CA-C-O 121.22 0.533 . . . . 0.0 111.102 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.487 ' HE2' ' CZ3' ' A' ' 10' ' ' TRP . 15.6 mtmt -43.89 -53.79 5.8 Favored 'General case' 0 CA--C 1.557 1.249 0 C-N-CA 127.001 2.121 . . . . 0.0 113.502 -178.052 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 59.71 -67.72 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 130.131 3.372 . . . . 0.0 115.138 172.088 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 14.5 m-80 72.02 26.29 2.89 Favored 'General case' 0 CA--C 1.55 0.978 0 C-N-CA 126.457 1.903 . . . . 0.0 112.861 173.142 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 16.3 m -61.02 148.25 84.56 Favored Pre-proline 0 CA--C 1.548 0.884 0 C-N-CA 124.929 1.292 . . . . 0.0 114.22 -172.345 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -77.47 -18.06 14.1 Favored 'Trans proline' 0 CA--C 1.541 0.837 0 C-N-CA 123.551 2.834 . . . . 0.0 112.959 170.238 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 51.18 16.61 0.39 Allowed 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 129.407 3.083 . . . . 0.0 116.757 176.076 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 74.84 34.17 0.72 Allowed 'General case' 0 CA--C 1.553 1.068 0 C-N-CA 129.135 2.974 . . . . 0.0 113.013 177.484 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 40.8 t -55.23 -41.13 59.31 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.333 0 C-N-CA 124.094 0.958 . . . . 0.0 111.902 173.225 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 10.7 t . . . . . 0 C--O 1.254 1.333 0 C-N-CA 124.796 1.238 . . . . 0.0 111.63 173.459 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 36.0 tptt . . . . . 0 N--CA 1.479 1.01 0 N-CA-C 112.694 0.627 . . . . 0.0 112.694 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -157.79 124.36 4.88 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 125.829 1.652 . . . . 0.0 111.095 179.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -68.23 -15.77 68.15 Favored Glycine 0 N--CA 1.479 1.509 0 C-N-CA 124.454 1.026 . . . . 0.0 114.759 -175.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 19.8 t -64.77 -22.21 30.9 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 C-N-CA 125.448 1.499 . . . . 0.0 111.897 170.39 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 98.88 31.89 6.12 Favored Glycine 0 CA--C 1.537 1.419 0 C-N-CA 124.746 1.165 . . . . 0.0 113.364 -170.73 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 41.3 mt-30 . . . . . 0 CA--C 1.544 0.746 0 C-N-CA 126.527 1.931 . . . . 0.0 113.133 178.479 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . 0.479 ' CZ3' ' HE2' ' A' ' 11' ' ' LYS . 57.6 p-90 . . . . . 0 CA--C 1.548 0.902 0 N-CA-C 108.447 -0.945 . . . . 0.0 108.447 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.479 ' HE2' ' CZ3' ' A' ' 10' ' ' TRP . 13.6 mtmt -50.35 -44.66 54.61 Favored 'General case' 0 CA--C 1.554 1.117 0 C-N-CA 125.509 1.523 . . . . 0.0 112.914 176.414 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 16.7 mm-40 58.02 -171.51 0.1 Allowed 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 128.212 2.605 . . . . 0.0 113.285 173.257 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 12.8 p30 -76.53 -16.98 59.49 Favored 'General case' 0 CA--C 1.551 0.989 0 O-C-N 120.998 -1.063 . . . . 0.0 113.267 174.081 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 15.4 m -73.66 157.34 87.68 Favored Pre-proline 0 CA--C 1.546 0.812 0 C-N-CA 125.133 1.373 . . . . 0.0 113.336 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -75.89 -19.19 16.26 Favored 'Trans proline' 0 CA--C 1.541 0.852 0 C-N-CA 122.842 2.362 . . . . 0.0 111.761 169.029 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 55.23 11.92 0.61 Allowed 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 129.311 3.044 . . . . 0.0 116.099 174.807 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 69.37 29.86 4.34 Favored 'General case' 0 CA--C 1.553 1.059 0 C-N-CA 128.775 2.83 . . . . 0.0 112.64 -175.224 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 5.0 p -66.53 -24.45 33.12 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.167 0 N-CA-C 113.789 1.033 . . . . 0.0 113.789 -177.054 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 41.1 m . . . . . 0 C--O 1.254 1.325 0 C-N-CA 125.881 1.672 . . . . 0.0 113.949 -177.782 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 75.8 m . . . . . 0 N--CA 1.494 1.768 0 CA-C-O 119.79 -0.147 . . . . 0.0 111.117 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 9.7 mmm180 60.21 -98.45 0.08 Allowed 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 126.248 1.819 . . . . 0.0 110.72 176.756 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -140.61 20.74 2.36 Favored 'General case' 0 CA--C 1.552 1.03 0 C-N-CA 125.597 1.559 . . . . 0.0 112.406 176.599 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -143.96 102.73 3.93 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.68 1.192 . . . . 0.0 111.926 -174.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -70.45 -18.58 75.47 Favored Glycine 0 N--CA 1.477 1.376 0 C-N-CA 124.418 1.009 . . . . 0.0 114.517 -179.324 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.0 t -72.03 -16.28 18.5 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.184 0 C-N-CA 124.882 1.273 . . . . 0.0 112.008 173.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 96.34 40.94 3.82 Favored Glycine 0 CA--C 1.534 1.277 0 C-N-CA 124.414 1.007 . . . . 0.0 113.535 -175.526 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 62.17 55.75 2.37 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 125.767 1.627 . . . . 0.0 111.724 -177.49 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 30.8 p-90 -156.8 -77.7 0.09 Allowed 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.856 1.662 . . . . 0.0 111.832 -177.068 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 5.3 mtmt -149.97 22.89 0.87 Allowed 'General case' 0 CA--C 1.557 1.222 0 C-N-CA 128.011 2.525 . . . . 0.0 111.1 -176.178 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 21.4 mt-10 -52.13 140.95 19.66 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 124.357 1.063 . . . . 0.0 113.485 -169.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 67.9 m-80 -76.84 -25.89 53.7 Favored 'General case' 0 CA--C 1.545 0.758 0 N-CA-C 113.55 0.944 . . . . 0.0 113.55 -173.331 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 27.6 m -73.52 151.85 89.55 Favored Pre-proline 0 CA--C 1.547 0.859 0 C-N-CA 123.92 0.888 . . . . 0.0 112.465 176.656 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -73.77 -18.1 22.34 Favored 'Trans proline' 0 CA--C 1.539 0.766 0 C-N-CA 122.988 2.459 . . . . 0.0 112.703 169.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 53.35 14.17 0.51 Allowed 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 129.67 3.188 . . . . 0.0 116.43 173.443 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 74.32 38.45 0.53 Allowed 'General case' 0 CA--C 1.552 1.055 0 C-N-CA 129.099 2.96 . . . . 0.0 112.908 178.741 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 36.2 t -57.31 -33.73 44.33 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 C-N-CA 124.372 1.069 . . . . 0.0 112.435 172.25 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 10.8 t . . . . . 0 C--O 1.255 1.378 0 C-N-CA 125.144 1.378 . . . . 0.0 113.32 179.809 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 35.9 t . . . . . 0 N--CA 1.491 1.603 0 CA-C-O 119.491 -0.29 . . . . 0.0 110.477 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -164.7 -49.64 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 124.73 1.212 . . . . 0.0 112.912 178.435 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 84.1 mttt 60.78 73.29 0.49 Allowed 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 126.638 1.975 . . . . 0.0 112.66 173.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -62.78 -26.77 68.88 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 125.421 1.488 . . . . 0.0 114.718 -172.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 77.74 -46.12 2.55 Favored Glycine 0 N--CA 1.478 1.455 0 C-N-CA 125.564 1.554 . . . . 0.0 114.031 176.417 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 4.1 m -60.7 -30.52 47.17 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.296 0 C-N-CA 125.032 1.333 . . . . 0.0 114.089 175.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 132.61 24.85 0.73 Allowed Glycine 0 N--CA 1.476 1.336 0 C-N-CA 125.503 1.525 . . . . 0.0 115.63 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 11.8 mt-30 63.41 44.31 5.5 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 125.697 1.599 . . . . 0.0 111.616 -179.291 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 38.3 p-90 -147.74 -79.37 0.15 Allowed 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 126.084 1.754 . . . . 0.0 111.794 179.458 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 6.0 mtmt -151.77 22.53 0.69 Allowed 'General case' 0 CA--C 1.556 1.173 0 C-N-CA 127.746 2.419 . . . . 0.0 111.672 -174.173 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 21.4 mt-10 -51.54 141.03 16.88 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 124.268 1.027 . . . . 0.0 113.753 -169.149 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 68.3 m-80 -81.85 -21.95 37.25 Favored 'General case' 0 CA--C 1.546 0.801 0 N-CA-C 113.625 0.972 . . . . 0.0 113.625 -174.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 22.8 m -71.86 152.76 93.16 Favored Pre-proline 0 N--CA 1.475 0.784 0 O-C-N 121.174 -0.954 . . . . 0.0 112.578 176.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -74.06 -17.59 21.99 Favored 'Trans proline' 0 CA--C 1.539 0.764 0 C-N-CA 123.002 2.468 . . . . 0.0 112.441 169.663 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 53.19 13.92 0.45 Allowed 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 129.664 3.186 . . . . 0.0 116.371 174.428 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 74.79 35.15 0.66 Allowed 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 129.136 2.974 . . . . 0.0 113.121 178.613 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 28.0 t -51.26 -44.06 29.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 C-N-CA 124.474 1.11 . . . . 0.0 111.646 174.057 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 5.6 t . . . . . 0 C--O 1.254 1.313 0 C-N-CA 127.273 2.229 . . . . 0.0 112.887 172.775 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 31.8 p . . . . . 0 N--CA 1.493 1.699 0 N-CA-C 111.442 0.164 . . . . 0.0 111.442 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 27.2 ptt-85 -63.07 143.61 57.63 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 124.007 0.923 . . . . 0.0 113.037 -178.645 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 14.4 tmtt? -168.32 103.95 0.45 Allowed 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 126.674 1.99 . . . . 0.0 110.291 -179.18 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -89.96 139.31 30.73 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 125.173 1.389 . . . . 0.0 111.227 173.658 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -79.13 43.26 2.45 Favored Glycine 0 N--CA 1.476 1.306 0 C-N-CA 125.167 1.365 . . . . 0.0 114.602 -176.078 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 5.6 p -168.83 -50.41 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.262 0 C-N-CA 125.566 1.547 . . . . 0.0 112.657 -177.481 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 145.54 52.6 0.03 OUTLIER Glycine 0 N--CA 1.477 1.392 0 C-N-CA 124.417 1.008 . . . . 0.0 114.906 -178.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 31.6 mt-30 61.03 42.68 12.29 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 126.049 1.74 . . . . 0.0 112.85 176.212 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 34.3 p-90 -147.49 -80.59 0.14 Allowed 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 125.41 1.484 . . . . 0.0 112.272 -178.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 6.8 mtmt -146.91 24.52 1.18 Allowed 'General case' 0 CA--C 1.555 1.17 0 C-N-CA 128.067 2.547 . . . . 0.0 110.877 -175.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -54.6 139.0 39.79 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 124.048 0.939 . . . . 0.0 112.497 -169.259 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 9.4 p30 -149.44 17.37 0.92 Allowed 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 124.54 1.136 . . . . 0.0 113.405 -171.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 18.6 m -70.22 154.63 94.4 Favored Pre-proline 0 CA--C 1.549 0.926 0 C-N-CA 125.1 1.36 . . . . 0.0 113.497 -175.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -73.75 -14.66 24.32 Favored 'Trans proline' 0 C--N 1.356 0.922 0 C-N-CA 123.618 2.879 . . . . 0.0 113.372 171.206 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . 0.275 1.8 pp 58.87 4.45 0.4 Allowed 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 130.368 3.467 . . . . 0.0 117.039 169.555 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 29.2 m120 77.5 47.0 0.06 Allowed 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 129.8 3.24 . . . . 0.0 111.789 177.224 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 56.0 t -62.93 -29.57 47.49 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.213 0 C-N-CA 124.361 1.065 . . . . 0.0 111.402 169.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 11.7 p . . . . . 0 C--O 1.253 1.275 0 C-N-CA 126.194 1.798 . . . . 0.0 114.654 175.6 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 47.0 t . . . . . 0 N--CA 1.49 1.574 0 CA-C-O 119.729 -0.177 . . . . 0.0 110.764 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 87.7 mtt-85 -139.16 110.02 6.75 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 125.182 1.393 . . . . 0.0 110.606 171.109 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 54.0 mtmt -112.27 74.05 0.85 Allowed 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 126.428 1.891 . . . . 0.0 108.71 171.288 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -13.97 96.25 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 128.987 2.915 . . . . 0.0 115.244 -169.602 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -67.26 -28.18 73.65 Favored Glycine 0 N--CA 1.479 1.524 0 C-N-CA 123.847 0.737 . . . . 0.0 113.796 -171.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.8 m -61.41 -27.56 42.18 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.158 0 C-N-CA 125.157 1.383 . . . . 0.0 113.286 169.542 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 137.63 123.91 2.24 Favored Glycine 0 CA--C 1.528 0.871 0 C-N-CA 128.011 2.719 . . . . 0.0 109.36 -172.648 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 32.9 mt-30 -72.95 65.67 0.75 Allowed 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 125.293 1.437 . . . . 0.0 111.145 171.677 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . 0.499 ' CZ3' ' HE2' ' A' ' 11' ' ' LYS . 30.2 p-90 -49.35 -64.89 0.67 Allowed 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 126.929 2.092 . . . . 0.0 114.242 179.635 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.499 ' HE2' ' CZ3' ' A' ' 10' ' ' TRP . 27.9 mtmt -145.3 -62.05 0.34 Allowed 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 126.457 1.903 . . . . 0.0 109.034 176.512 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 62.54 171.71 0.14 Allowed 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 128.751 2.82 . . . . 0.0 113.191 178.291 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 69.0 m-80 -112.31 0.87 15.85 Favored 'General case' 0 CA--C 1.549 0.918 0 N-CA-C 114.034 1.124 . . . . 0.0 114.034 -176.244 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 15.8 m -69.76 150.19 96.62 Favored Pre-proline 0 N--CA 1.475 0.823 0 O-C-N 120.712 -1.243 . . . . 0.0 113.614 -175.711 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -76.34 -16.19 17.47 Favored 'Trans proline' 0 CA--C 1.541 0.83 0 C-N-CA 123.33 2.687 . . . . 0.0 112.136 169.383 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 54.17 14.35 0.72 Allowed 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 129.69 3.196 . . . . 0.0 116.498 175.038 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 78.77 33.25 0.27 Allowed 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 129.343 3.057 . . . . 0.0 113.235 172.486 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 47.3 t -56.5 -32.57 36.84 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.381 0 C-N-CA 124.745 1.218 . . . . 0.0 112.251 175.152 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 77.7 p . . . . . 0 C--O 1.253 1.239 0 C-N-CA 125.935 1.694 . . . . 0.0 113.468 179.425 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 80.5 m . . . . . 0 N--CA 1.492 1.66 0 CA-C-O 118.898 -0.572 . . . . 0.0 111.04 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 12.7 ptp180 -153.65 145.4 23.42 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 125.245 1.418 . . . . 0.0 112.187 178.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 4.4 tmtm? -162.9 44.36 0.13 Allowed 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 125.021 1.328 . . . . 0.0 112.209 -173.735 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -169.8 151.75 4.3 Favored 'General case' 0 N--CA 1.481 1.075 0 C-N-CA 127.138 2.175 . . . . 0.0 111.232 -179.368 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -155.1 -46.8 0.02 OUTLIER Glycine 0 N--CA 1.479 1.518 0 C-N-CA 124.984 1.278 . . . . 0.0 114.643 -179.591 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.4 t -41.48 -56.49 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 C-N-CA 126.812 2.045 . . . . 0.0 113.379 177.109 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -140.52 -18.0 0.41 Allowed Glycine 0 N--CA 1.477 1.393 0 C-N-CA 124.244 0.926 . . . . 0.0 115.382 177.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 99.1 mt-30 56.43 45.83 21.9 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 125.821 1.648 . . . . 0.0 113.368 177.103 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 49.3 p-90 -76.67 -95.26 0.02 OUTLIER 'General case' 0 CA--C 1.546 0.794 0 O-C-N 121.214 -0.929 . . . . 0.0 112.776 -170.601 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 22.1 mtmt -115.22 -23.78 8.79 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 127.196 2.198 . . . . 0.0 111.252 175.108 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 19.26 -88.76 0.0 OUTLIER 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 131.32 3.848 . . . . 0.0 114.623 -175.142 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 69.1 m-80 -130.28 23.27 5.19 Favored 'General case' 0 CA--C 1.553 1.059 0 C-N-CA 126.933 2.093 . . . . 0.0 111.93 179.294 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 35.3 m -114.93 154.08 47.03 Favored Pre-proline 0 N--CA 1.476 0.837 0 C-N-CA 125.284 1.433 . . . . 0.0 113.251 -169.76 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -78.28 -15.81 14.1 Favored 'Trans proline' 0 CA--C 1.541 0.837 0 C-N-CA 123.311 2.674 . . . . 0.0 112.304 169.288 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 52.25 15.52 0.47 Allowed 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 129.406 3.083 . . . . 0.0 116.38 177.063 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 72.2 26.59 2.72 Favored 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 129.309 3.044 . . . . 0.0 112.715 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 5.3 p -65.75 -25.97 37.7 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.241 0 C-N-CA 124.251 1.02 . . . . 0.0 113.675 -175.091 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 11.2 t . . . . . 0 C--O 1.256 1.419 0 C-N-CA 125.608 1.563 . . . . 0.0 111.63 175.935 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 27.6 p . . . . . 0 N--CA 1.491 1.604 0 CA-C-O 119.596 -0.24 . . . . 0.0 111.616 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 9.3 mtt85 172.03 163.44 0.1 Allowed 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 129.018 2.927 . . . . 0.0 111.555 176.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 38.2 pttt -137.07 -68.51 0.48 Allowed 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 125.678 1.591 . . . . 0.0 111.19 178.428 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -155.79 151.08 26.79 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 126.067 1.747 . . . . 0.0 109.989 169.394 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -71.19 -37.09 63.67 Favored Glycine 0 N--CA 1.478 1.483 0 C-N-CA 123.397 0.522 . . . . 0.0 112.59 179.512 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.5 m -64.75 -32.32 57.51 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.223 0 C-N-CA 124.912 1.285 . . . . 0.0 112.99 169.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 133.39 -77.03 0.39 Allowed Glycine 0 N--CA 1.469 0.854 0 C-N-CA 126.576 2.036 . . . . 0.0 111.929 177.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 16.1 mp0 -140.75 14.68 2.31 Favored 'General case' 0 CA--C 1.555 1.143 0 C-N-CA 124.918 1.287 . . . . 0.0 112.546 -173.498 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . 0.462 ' CZ3' ' HE2' ' A' ' 11' ' ' LYS . 32.7 p-90 -161.55 -164.28 1.1 Allowed 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 126.747 2.019 . . . . 0.0 112.869 -178.492 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.462 ' HE2' ' CZ3' ' A' ' 10' ' ' TRP . 14.8 mtmt -46.16 -42.97 14.67 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 127.739 2.416 . . . . 0.0 114.62 -177.638 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 29.89 -99.09 0.01 OUTLIER 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 129.074 2.95 . . . . 0.0 114.134 -170.371 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -162.68 35.3 0.11 Allowed 'General case' 0 CA--C 1.55 0.972 0 C-N-CA 126.642 1.977 . . . . 0.0 111.676 -169.606 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 44.7 m -133.23 152.4 79.41 Favored Pre-proline 0 N--CA 1.478 0.958 0 C-N-CA 124.299 1.04 . . . . 0.0 112.79 -172.528 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -77.94 -16.78 14.14 Favored 'Trans proline' 0 C--N 1.354 0.821 0 C-N-CA 123.556 2.837 . . . . 0.0 112.792 169.783 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 50.62 17.11 0.35 Allowed 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 129.603 3.161 . . . . 0.0 116.54 176.907 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 77.04 32.2 0.49 Allowed 'General case' 0 CA--C 1.551 1.019 0 C-N-CA 129.549 3.14 . . . . 0.0 113.375 174.895 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 42.8 t -56.03 -33.64 36.4 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 C-N-CA 124.513 1.125 . . . . 0.0 112.291 174.26 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 77.5 p . . . . . 0 C--O 1.252 1.233 0 C-N-CA 125.949 1.699 . . . . 0.0 113.372 179.467 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 78.3 m . . . . . 0 N--CA 1.493 1.698 0 CA-C-O 119.739 -0.172 . . . . 0.0 111.207 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 57.4 mtm180 54.23 41.24 32.09 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 125.801 1.64 . . . . 0.0 113.719 174.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 55.2 tttp -78.67 -52.86 7.83 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 124.364 1.066 . . . . 0.0 112.797 -173.641 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -94.92 -32.31 13.27 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 124.65 1.18 . . . . 0.0 113.481 178.188 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 72.64 19.82 79.33 Favored Glycine 0 CA--C 1.537 1.43 0 C-N-CA 124.127 0.87 . . . . 0.0 114.185 -173.457 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 48.4 t -149.95 -68.64 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 C-N-CA 126.48 1.912 . . . . 0.0 109.21 -172.506 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 158.46 42.21 0.02 OUTLIER Glycine 0 CA--C 1.536 1.353 0 C-N-CA 125.316 1.436 . . . . 0.0 113.41 -178.406 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 40.5 mt-30 55.8 39.21 30.73 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 126.043 1.737 . . . . 0.0 112.099 -169.751 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . 0.449 ' CZ3' ' HE2' ' A' ' 11' ' ' LYS . 51.0 p-90 -165.9 -156.6 0.27 Allowed 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 128.29 2.636 . . . . 0.0 110.089 176.529 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.449 ' HE2' ' CZ3' ' A' ' 10' ' ' TRP . 13.7 mtmt -47.85 -39.99 20.1 Favored 'General case' 0 CA--C 1.552 1.046 0 C-N-CA 126.548 1.939 . . . . 0.0 113.808 178.553 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 19.4 mm-40 46.28 -104.54 0.1 Allowed 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 128.286 2.634 . . . . 0.0 112.016 175.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 5.3 p30 -176.88 -48.84 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 127.842 2.457 . . . . 0.0 110.328 174.212 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 21.2 m 71.92 156.82 0.16 Allowed Pre-proline 0 CA--C 1.551 1.019 0 C-N-CA 127.583 2.353 . . . . 0.0 113.744 172.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -76.86 -22.94 11.26 Favored 'Trans proline' 0 C--N 1.354 0.844 0 C-N-CA 122.926 2.417 . . . . 0.0 112.725 170.111 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 50.3 15.87 0.23 Allowed 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 129.496 3.118 . . . . 0.0 116.815 175.379 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 69.78 41.34 1.21 Allowed 'General case' 0 CA--C 1.553 1.065 0 C-N-CA 128.802 2.841 . . . . 0.0 113.083 -178.562 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 42.5 t -58.35 -33.99 49.11 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 C-N-CA 124.053 0.941 . . . . 0.0 112.356 170.337 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 76.2 p . . . . . 0 C--O 1.255 1.365 0 C-N-CA 126.923 2.089 . . . . 0.0 114.828 178.678 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 7.7 p . . . . . 0 N--CA 1.494 1.752 0 CA-C-O 121.143 0.497 . . . . 0.0 111.885 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.9 99.29 11.1 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 124.704 1.201 . . . . 0.0 110.818 -176.792 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 24.7 mtpp 48.79 37.86 10.69 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 126.263 1.825 . . . . 0.0 114.31 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . 112.22 -36.6 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.303 1 C-N-CA 132.031 4.132 . . . . 0.0 112.541 -179.066 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 73.48 -55.47 2.01 Favored Glycine 0 CA--C 1.532 1.118 0 C-N-CA 126.386 1.946 . . . . 0.0 112.889 -175.092 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 4.8 p -74.78 -38.16 43.83 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.13 0 C-N-CA 125.584 1.554 . . . . 0.0 113.13 -176.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 170.93 -83.47 0.08 OUTLIER Glycine 0 N--CA 1.47 0.921 0 C-N-CA 124.967 1.27 . . . . 0.0 112.803 -175.74 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 6.4 mt-30 -177.86 53.59 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 129.098 2.959 . . . . 0.0 109.672 -179.7 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 41.9 p-90 -151.54 -83.71 0.09 Allowed 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 125.565 1.546 . . . . 0.0 112.229 -175.026 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 4.6 mtmt -147.5 23.32 1.14 Allowed 'General case' 0 CA--C 1.557 1.221 0 C-N-CA 127.991 2.516 . . . . 0.0 111.075 -174.668 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -49.73 139.99 12.13 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 124.703 1.201 . . . . 0.0 113.928 -168.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 11.8 p30 -74.0 -18.24 60.88 Favored 'General case' 0 CA--C 1.547 0.841 0 N-CA-C 113.695 0.998 . . . . 0.0 113.695 -178.75 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 21.2 m -72.27 154.33 92.07 Favored Pre-proline 0 CA--C 1.548 0.892 0 C-N-CA 124.864 1.265 . . . . 0.0 112.915 177.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -75.89 -15.48 18.81 Favored 'Trans proline' 0 CA--C 1.541 0.825 0 C-N-CA 123.445 2.763 . . . . 0.0 112.789 169.66 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 51.94 19.89 1.09 Allowed 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 129.241 3.016 . . . . 0.0 116.204 173.491 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . 0.273 12.0 p30 51.29 37.77 19.63 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 129.278 3.031 . . . . 0.0 113.539 -173.241 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 6.9 p -67.77 -26.78 35.89 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.183 0 N-CA-C 113.309 0.855 . . . . 0.0 113.309 -179.611 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 71.0 m . . . . . 0 C--O 1.252 1.228 0 C-N-CA 126.955 2.102 . . . . 0.0 113.13 176.008 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 85.6 m . . . . . 0 N--CA 1.493 1.703 0 CA-C-O 118.932 -0.556 . . . . 0.0 112.209 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -75.59 124.3 26.98 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 124.981 1.312 . . . . 0.0 113.022 -174.4 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 19.0 pttp -167.2 34.1 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 126.799 2.04 . . . . 0.0 113.077 -175.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -139.3 -46.19 0.46 Allowed 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 114.449 1.277 . . . . 0.0 114.449 -171.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 77.34 25.08 64.29 Favored Glycine 0 CA--C 1.54 1.614 0 C-N-CA 123.93 0.776 . . . . 0.0 114.212 -173.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.1 m -156.49 -39.41 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 C-N-CA 126.677 1.991 . . . . 0.0 113.153 -172.748 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 118.46 62.05 0.29 Allowed Glycine 0 N--CA 1.474 1.174 0 C-N-CA 125.077 1.322 . . . . 0.0 112.922 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 37.9 mt-30 62.19 33.86 16.52 Favored 'General case' 0 CA--C 1.553 1.077 0 C-N-CA 125.942 1.697 . . . . 0.0 113.707 176.393 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . 0.487 ' CZ3' ' HE2' ' A' ' 11' ' ' LYS . 46.6 p-90 -163.08 -162.25 0.75 Allowed 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 127.641 2.376 . . . . 0.0 111.102 176.075 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.487 ' HE2' ' CZ3' ' A' ' 10' ' ' TRP . 15.6 mtmt -43.89 -53.79 5.8 Favored 'General case' 0 CA--C 1.557 1.249 0 C-N-CA 127.001 2.121 . . . . 0.0 113.502 -178.052 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 59.71 -67.72 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 130.131 3.372 . . . . 0.0 115.138 172.088 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 14.5 m-80 72.02 26.29 2.89 Favored 'General case' 0 CA--C 1.55 0.978 0 C-N-CA 126.457 1.903 . . . . 0.0 112.861 173.142 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 16.3 m -61.02 148.25 84.56 Favored Pre-proline 0 CA--C 1.548 0.884 0 C-N-CA 124.929 1.292 . . . . 0.0 114.22 -172.345 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -77.47 -18.06 14.1 Favored 'Trans proline' 0 CA--C 1.541 0.837 0 C-N-CA 123.551 2.834 . . . . 0.0 112.959 170.238 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 51.18 16.61 0.39 Allowed 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 129.407 3.083 . . . . 0.0 116.757 176.076 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 74.84 34.17 0.72 Allowed 'General case' 0 CA--C 1.553 1.068 0 C-N-CA 129.135 2.974 . . . . 0.0 113.013 177.484 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 40.8 t -55.23 -41.13 59.31 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.333 0 C-N-CA 124.094 0.958 . . . . 0.0 111.902 173.225 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 10.7 t . . . . . 0 C--O 1.254 1.333 0 C-N-CA 124.796 1.238 . . . . 0.0 111.63 173.459 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 87.7 m . . . . . 0 N--CA 1.492 1.63 0 CA-C-O 119.064 -0.494 . . . . 0.0 111.907 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 4.2 ppt_? -60.16 138.58 57.88 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 124.127 0.971 . . . . 0.0 113.556 -174.338 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 36.0 tptt -168.34 -45.78 0.02 OUTLIER 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 125.662 1.585 . . . . 0.0 112.694 179.616 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -157.79 124.36 4.88 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 125.829 1.652 . . . . 0.0 111.095 179.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -68.23 -15.77 68.15 Favored Glycine 0 N--CA 1.479 1.509 0 C-N-CA 124.454 1.026 . . . . 0.0 114.759 -175.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 19.8 t -64.77 -22.21 30.9 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 C-N-CA 125.448 1.499 . . . . 0.0 111.897 170.39 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 98.88 31.89 6.12 Favored Glycine 0 CA--C 1.537 1.419 0 C-N-CA 124.746 1.165 . . . . 0.0 113.364 -170.73 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 41.3 mt-30 66.48 60.81 0.58 Allowed 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 126.527 1.931 . . . . 0.0 113.133 178.479 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . 0.479 ' CZ3' ' HE2' ' A' ' 11' ' ' LYS . 57.6 p-90 -169.33 -153.43 0.11 Allowed 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 130.028 3.331 . . . . 0.0 108.447 178.865 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.479 ' HE2' ' CZ3' ' A' ' 10' ' ' TRP . 13.6 mtmt -50.35 -44.66 54.61 Favored 'General case' 0 CA--C 1.554 1.117 0 C-N-CA 125.509 1.523 . . . . 0.0 112.914 176.414 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 16.7 mm-40 58.02 -171.51 0.1 Allowed 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 128.212 2.605 . . . . 0.0 113.285 173.257 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 12.8 p30 -76.53 -16.98 59.49 Favored 'General case' 0 CA--C 1.551 0.989 0 O-C-N 120.998 -1.063 . . . . 0.0 113.267 174.081 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 15.4 m -73.66 157.34 87.68 Favored Pre-proline 0 CA--C 1.546 0.812 0 C-N-CA 125.133 1.373 . . . . 0.0 113.336 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -75.89 -19.19 16.26 Favored 'Trans proline' 0 CA--C 1.541 0.852 0 C-N-CA 122.842 2.362 . . . . 0.0 111.761 169.029 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 55.23 11.92 0.61 Allowed 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 129.311 3.044 . . . . 0.0 116.099 174.807 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 69.37 29.86 4.34 Favored 'General case' 0 CA--C 1.553 1.059 0 C-N-CA 128.775 2.83 . . . . 0.0 112.64 -175.224 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 5.0 p -66.53 -24.45 33.12 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.167 0 N-CA-C 113.789 1.033 . . . . 0.0 113.789 -177.054 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 41.1 m . . . . . 0 C--O 1.254 1.325 0 C-N-CA 125.881 1.672 . . . . 0.0 113.949 -177.782 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 CA--C 1.552 1.03 0 N-CA-C 112.406 0.521 . . . . 0.0 112.406 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -143.96 102.73 3.93 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.68 1.192 . . . . 0.0 111.926 -174.837 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -70.45 -18.58 75.47 Favored Glycine 0 N--CA 1.477 1.376 0 C-N-CA 124.418 1.009 . . . . 0.0 114.517 -179.324 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.0 t -72.03 -16.28 18.5 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.184 0 C-N-CA 124.882 1.273 . . . . 0.0 112.008 173.758 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 96.34 40.94 3.82 Favored Glycine 0 CA--C 1.534 1.277 0 C-N-CA 124.414 1.007 . . . . 0.0 113.535 -175.526 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 . . . . . 0 N--CA 1.477 0.918 0 C-N-CA 125.767 1.627 . . . . 0.0 111.724 -177.49 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 10' ' ' TRP . . . . . 0.405 ' CE2' ' HG2' ' A' ' 12' ' ' GLU . 30.8 p-90 . . . . . 0 CA--C 1.543 0.674 0 CA-C-O 120.89 0.376 . . . . 0.0 111.832 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 5.3 mtmt -149.97 22.89 0.87 Allowed 'General case' 0 CA--C 1.557 1.222 0 C-N-CA 128.011 2.525 . . . . 0.0 111.1 -176.178 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.405 ' HG2' ' CE2' ' A' ' 10' ' ' TRP . 21.4 mt-10 -52.13 140.95 19.66 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 124.357 1.063 . . . . 0.0 113.485 -169.0 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 67.9 m-80 -76.84 -25.89 53.7 Favored 'General case' 0 CA--C 1.545 0.758 0 N-CA-C 113.55 0.944 . . . . 0.0 113.55 -173.331 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 27.6 m -73.52 151.85 89.55 Favored Pre-proline 0 CA--C 1.547 0.859 0 C-N-CA 123.92 0.888 . . . . 0.0 112.465 176.656 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -73.77 -18.1 22.34 Favored 'Trans proline' 0 CA--C 1.539 0.766 0 C-N-CA 122.988 2.459 . . . . 0.0 112.703 169.793 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 53.35 14.17 0.51 Allowed 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 129.67 3.188 . . . . 0.0 116.43 173.443 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 74.32 38.45 0.53 Allowed 'General case' 0 CA--C 1.552 1.055 0 C-N-CA 129.099 2.96 . . . . 0.0 112.908 178.741 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 36.2 t -57.31 -33.73 44.33 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 C-N-CA 124.372 1.069 . . . . 0.0 112.435 172.25 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 10.8 t . . . . . 0 C--O 1.255 1.378 0 C-N-CA 125.144 1.378 . . . . 0.0 113.32 179.809 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 84.1 mttt . . . . . 0 N--CA 1.48 1.057 0 CA-C-O 121.872 0.844 . . . . 0.0 112.66 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -62.78 -26.77 68.88 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 125.421 1.488 . . . . 0.0 114.718 -172.975 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 77.74 -46.12 2.55 Favored Glycine 0 N--CA 1.478 1.455 0 C-N-CA 125.564 1.554 . . . . 0.0 114.031 176.417 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 4.1 m -60.7 -30.52 47.17 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.296 0 C-N-CA 125.032 1.333 . . . . 0.0 114.089 175.974 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 132.61 24.85 0.73 Allowed Glycine 0 N--CA 1.476 1.336 0 C-N-CA 125.503 1.525 . . . . 0.0 115.63 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 11.8 mt-30 . . . . . 0 N--CA 1.479 0.978 0 C-N-CA 125.697 1.599 . . . . 0.0 111.616 -179.291 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 38.3 p-90 . . . . . 0 CA--C 1.543 0.675 0 N-CA-C 111.794 0.294 . . . . 0.0 111.794 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 6.0 mtmt -151.77 22.53 0.69 Allowed 'General case' 0 CA--C 1.556 1.173 0 C-N-CA 127.746 2.419 . . . . 0.0 111.672 -174.173 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 21.4 mt-10 -51.54 141.03 16.88 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 124.268 1.027 . . . . 0.0 113.753 -169.149 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 68.3 m-80 -81.85 -21.95 37.25 Favored 'General case' 0 CA--C 1.546 0.801 0 N-CA-C 113.625 0.972 . . . . 0.0 113.625 -174.907 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 22.8 m -71.86 152.76 93.16 Favored Pre-proline 0 N--CA 1.475 0.784 0 O-C-N 121.174 -0.954 . . . . 0.0 112.578 176.935 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -74.06 -17.59 21.99 Favored 'Trans proline' 0 CA--C 1.539 0.764 0 C-N-CA 123.002 2.468 . . . . 0.0 112.441 169.663 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 53.19 13.92 0.45 Allowed 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 129.664 3.186 . . . . 0.0 116.371 174.428 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 74.79 35.15 0.66 Allowed 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 129.136 2.974 . . . . 0.0 113.121 178.613 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 28.0 t -51.26 -44.06 29.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 C-N-CA 124.474 1.11 . . . . 0.0 111.646 174.057 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 5.6 t . . . . . 0 C--O 1.254 1.313 0 C-N-CA 127.273 2.229 . . . . 0.0 112.887 172.775 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 14.4 tmtt? . . . . . 0 N--CA 1.474 0.747 0 CA-C-O 121.208 0.527 . . . . 0.0 110.291 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.445 ' HB3' ' H ' ' A' ' 8' ' ' GLN . . . -89.96 139.31 30.73 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 125.173 1.389 . . . . 0.0 111.227 173.658 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -79.13 43.26 2.45 Favored Glycine 0 N--CA 1.476 1.306 0 C-N-CA 125.167 1.365 . . . . 0.0 114.602 -176.078 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 5.6 p -168.83 -50.41 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.262 0 C-N-CA 125.566 1.547 . . . . 0.0 112.657 -177.481 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 145.54 52.6 0.03 OUTLIER Glycine 0 N--CA 1.477 1.392 0 C-N-CA 124.417 1.008 . . . . 0.0 114.906 -178.903 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' GLN . . . . . 0.445 ' H ' ' HB3' ' A' ' 4' ' ' ALA . 31.6 mt-30 . . . . . 0 N--CA 1.48 1.04 0 C-N-CA 126.049 1.74 . . . . 0.0 112.85 176.212 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 34.3 p-90 . . . . . 0 CA--C 1.545 0.757 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 6.8 mtmt -146.91 24.52 1.18 Allowed 'General case' 0 CA--C 1.555 1.17 0 C-N-CA 128.067 2.547 . . . . 0.0 110.877 -175.821 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -54.6 139.0 39.79 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 124.048 0.939 . . . . 0.0 112.497 -169.259 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 9.4 p30 -149.44 17.37 0.92 Allowed 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 124.54 1.136 . . . . 0.0 113.405 -171.913 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 18.6 m -70.22 154.63 94.4 Favored Pre-proline 0 CA--C 1.549 0.926 0 C-N-CA 125.1 1.36 . . . . 0.0 113.497 -175.755 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -73.75 -14.66 24.32 Favored 'Trans proline' 0 C--N 1.356 0.922 0 C-N-CA 123.618 2.879 . . . . 0.0 113.372 171.206 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . 0.275 1.8 pp 58.87 4.45 0.4 Allowed 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 130.368 3.467 . . . . 0.0 117.039 169.555 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 29.2 m120 77.5 47.0 0.06 Allowed 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 129.8 3.24 . . . . 0.0 111.789 177.224 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 56.0 t -62.93 -29.57 47.49 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.213 0 C-N-CA 124.361 1.065 . . . . 0.0 111.402 169.916 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 11.7 p . . . . . 0 C--O 1.253 1.275 0 C-N-CA 126.194 1.798 . . . . 0.0 114.654 175.6 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 54.0 mtmt . . . . . 0 CA--C 1.544 0.728 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -13.97 96.25 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 128.987 2.915 . . . . 0.0 115.244 -169.602 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -67.26 -28.18 73.65 Favored Glycine 0 N--CA 1.479 1.524 0 C-N-CA 123.847 0.737 . . . . 0.0 113.796 -171.789 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.8 m -61.41 -27.56 42.18 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.158 0 C-N-CA 125.157 1.383 . . . . 0.0 113.286 169.542 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 137.63 123.91 2.24 Favored Glycine 0 CA--C 1.528 0.871 0 C-N-CA 128.011 2.719 . . . . 0.0 109.36 -172.648 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 32.9 mt-30 . . . . . 0 N--CA 1.473 0.687 0 C-N-CA 125.293 1.437 . . . . 0.0 111.145 171.677 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 10' ' ' TRP . . . . . 0.482 ' CZ3' ' HE3' ' A' ' 11' ' ' LYS . 30.2 p-90 . . . . . 0 CA--C 1.542 0.66 0 N-CA-C 114.242 1.201 . . . . 0.0 114.242 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.482 ' HE3' ' CZ3' ' A' ' 10' ' ' TRP . 27.9 mtmt -145.3 -62.05 0.34 Allowed 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 126.457 1.903 . . . . 0.0 109.034 176.512 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 62.54 171.71 0.14 Allowed 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 128.751 2.82 . . . . 0.0 113.191 178.291 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 69.0 m-80 -112.31 0.87 15.85 Favored 'General case' 0 CA--C 1.549 0.918 0 N-CA-C 114.034 1.124 . . . . 0.0 114.034 -176.244 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 15.8 m -69.76 150.19 96.62 Favored Pre-proline 0 N--CA 1.475 0.823 0 O-C-N 120.712 -1.243 . . . . 0.0 113.614 -175.711 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -76.34 -16.19 17.47 Favored 'Trans proline' 0 CA--C 1.541 0.83 0 C-N-CA 123.33 2.687 . . . . 0.0 112.136 169.383 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 54.17 14.35 0.72 Allowed 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 129.69 3.196 . . . . 0.0 116.498 175.038 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 78.77 33.25 0.27 Allowed 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 129.343 3.057 . . . . 0.0 113.235 172.486 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 47.3 t -56.5 -32.57 36.84 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.381 0 C-N-CA 124.745 1.218 . . . . 0.0 112.251 175.152 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 77.7 p . . . . . 0 C--O 1.253 1.239 0 C-N-CA 125.935 1.694 . . . . 0.0 113.468 179.425 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 4.4 tmtm? . . . . . 0 N--CA 1.48 1.065 0 N-CA-C 112.209 0.448 . . . . 0.0 112.209 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -169.8 151.75 4.3 Favored 'General case' 0 N--CA 1.481 1.075 0 C-N-CA 127.138 2.175 . . . . 0.0 111.232 -179.368 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -155.1 -46.8 0.02 OUTLIER Glycine 0 N--CA 1.479 1.518 0 C-N-CA 124.984 1.278 . . . . 0.0 114.643 -179.591 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.4 t -41.48 -56.49 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 C-N-CA 126.812 2.045 . . . . 0.0 113.379 177.109 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -140.52 -18.0 0.41 Allowed Glycine 0 N--CA 1.477 1.393 0 C-N-CA 124.244 0.926 . . . . 0.0 115.382 177.821 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 99.1 mt-30 . . . . . 0 CA--C 1.545 0.773 0 C-N-CA 125.821 1.648 . . . . 0.0 113.368 177.103 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 49.3 p-90 . . . . . 0 CA--C 1.546 0.794 0 CA-C-O 121.519 0.676 . . . . 0.0 112.776 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 22.1 mtmt -115.22 -23.78 8.79 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 127.196 2.198 . . . . 0.0 111.252 175.108 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 19.26 -88.76 0.0 OUTLIER 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 131.32 3.848 . . . . 0.0 114.623 -175.142 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 69.1 m-80 -130.28 23.27 5.19 Favored 'General case' 0 CA--C 1.553 1.059 0 C-N-CA 126.933 2.093 . . . . 0.0 111.93 179.294 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 35.3 m -114.93 154.08 47.03 Favored Pre-proline 0 N--CA 1.476 0.837 0 C-N-CA 125.284 1.433 . . . . 0.0 113.251 -169.76 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -78.28 -15.81 14.1 Favored 'Trans proline' 0 CA--C 1.541 0.837 0 C-N-CA 123.311 2.674 . . . . 0.0 112.304 169.288 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 52.25 15.52 0.47 Allowed 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 129.406 3.083 . . . . 0.0 116.38 177.063 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 72.2 26.59 2.72 Favored 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 129.309 3.044 . . . . 0.0 112.715 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 5.3 p -65.75 -25.97 37.7 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.241 0 C-N-CA 124.251 1.02 . . . . 0.0 113.675 -175.091 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 11.2 t . . . . . 0 C--O 1.256 1.419 0 C-N-CA 125.608 1.563 . . . . 0.0 111.63 175.935 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 38.2 pttt . . . . . 0 N--CA 1.481 1.079 0 CA-C-O 119.709 -0.186 . . . . 0.0 111.19 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.437 ' HB2' ' CD1' ' A' ' 10' ' ' TRP . . . -155.79 151.08 26.79 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 126.067 1.747 . . . . 0.0 109.989 169.394 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -71.19 -37.09 63.67 Favored Glycine 0 N--CA 1.478 1.483 0 C-N-CA 123.397 0.522 . . . . 0.0 112.59 179.512 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.5 m -64.75 -32.32 57.51 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.223 0 C-N-CA 124.912 1.285 . . . . 0.0 112.99 169.859 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 133.39 -77.03 0.39 Allowed Glycine 0 N--CA 1.469 0.854 0 C-N-CA 126.576 2.036 . . . . 0.0 111.929 177.951 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 16.1 mp0 . . . . . 0 CA--C 1.555 1.143 0 C-N-CA 124.918 1.287 . . . . 0.0 112.546 -173.498 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 10' ' ' TRP . . . . . 0.448 ' CZ3' ' HE3' ' A' ' 11' ' ' LYS . 32.7 p-90 . . . . . 0 CA--C 1.549 0.909 0 CA-C-O 121.619 0.723 . . . . 0.0 112.869 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.448 ' HE3' ' CZ3' ' A' ' 10' ' ' TRP . 14.8 mtmt -46.16 -42.97 14.67 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 127.739 2.416 . . . . 0.0 114.62 -177.638 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 29.89 -99.09 0.01 OUTLIER 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 129.074 2.95 . . . . 0.0 114.134 -170.371 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -162.68 35.3 0.11 Allowed 'General case' 0 CA--C 1.55 0.972 0 C-N-CA 126.642 1.977 . . . . 0.0 111.676 -169.606 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 44.7 m -133.23 152.4 79.41 Favored Pre-proline 0 N--CA 1.478 0.958 0 C-N-CA 124.299 1.04 . . . . 0.0 112.79 -172.528 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -77.94 -16.78 14.14 Favored 'Trans proline' 0 C--N 1.354 0.821 0 C-N-CA 123.556 2.837 . . . . 0.0 112.792 169.783 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 50.62 17.11 0.35 Allowed 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 129.603 3.161 . . . . 0.0 116.54 176.907 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 77.04 32.2 0.49 Allowed 'General case' 0 CA--C 1.551 1.019 0 C-N-CA 129.549 3.14 . . . . 0.0 113.375 174.895 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 42.8 t -56.03 -33.64 36.4 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 C-N-CA 124.513 1.125 . . . . 0.0 112.291 174.26 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 77.5 p . . . . . 0 C--O 1.252 1.233 0 C-N-CA 125.949 1.699 . . . . 0.0 113.372 179.467 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 55.2 tttp . . . . . 0 N--CA 1.476 0.84 0 N-CA-C 112.797 0.666 . . . . 0.0 112.797 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -94.92 -32.31 13.27 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 124.65 1.18 . . . . 0.0 113.481 178.188 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 72.64 19.82 79.33 Favored Glycine 0 CA--C 1.537 1.43 0 C-N-CA 124.127 0.87 . . . . 0.0 114.185 -173.457 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 48.4 t -149.95 -68.64 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 C-N-CA 126.48 1.912 . . . . 0.0 109.21 -172.506 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 158.46 42.21 0.02 OUTLIER Glycine 0 CA--C 1.536 1.353 0 C-N-CA 125.316 1.436 . . . . 0.0 113.41 -178.406 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 40.5 mt-30 . . . . . 0 N--CA 1.479 0.989 0 C-N-CA 126.043 1.737 . . . . 0.0 112.099 -169.751 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 10' ' ' TRP . . . . . 0.43 ' CZ3' ' HE3' ' A' ' 11' ' ' LYS . 51.0 p-90 . . . . . 0 CA--C 1.545 0.77 0 CA-C-O 120.915 0.388 . . . . 0.0 110.089 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.43 ' HE3' ' CZ3' ' A' ' 10' ' ' TRP . 13.7 mtmt -47.85 -39.99 20.1 Favored 'General case' 0 CA--C 1.552 1.046 0 C-N-CA 126.548 1.939 . . . . 0.0 113.808 178.553 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 19.4 mm-40 46.28 -104.54 0.1 Allowed 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 128.286 2.634 . . . . 0.0 112.016 175.762 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 5.3 p30 -176.88 -48.84 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 127.842 2.457 . . . . 0.0 110.328 174.212 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 21.2 m 71.92 156.82 0.16 Allowed Pre-proline 0 CA--C 1.551 1.019 0 C-N-CA 127.583 2.353 . . . . 0.0 113.744 172.941 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -76.86 -22.94 11.26 Favored 'Trans proline' 0 C--N 1.354 0.844 0 C-N-CA 122.926 2.417 . . . . 0.0 112.725 170.111 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 50.3 15.87 0.23 Allowed 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 129.496 3.118 . . . . 0.0 116.815 175.379 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 69.78 41.34 1.21 Allowed 'General case' 0 CA--C 1.553 1.065 0 C-N-CA 128.802 2.841 . . . . 0.0 113.083 -178.562 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 42.5 t -58.35 -33.99 49.11 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 C-N-CA 124.053 0.941 . . . . 0.0 112.356 170.337 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 76.2 p . . . . . 0 C--O 1.255 1.365 0 C-N-CA 126.923 2.089 . . . . 0.0 114.828 178.678 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 24.7 mtpp . . . . . 0 N--CA 1.485 1.303 0 N-CA-C 114.31 1.226 . . . . 0.0 114.31 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . 112.22 -36.6 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.303 1 C-N-CA 132.031 4.132 . . . . 0.0 112.541 -179.066 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 73.48 -55.47 2.01 Favored Glycine 0 CA--C 1.532 1.118 0 C-N-CA 126.386 1.946 . . . . 0.0 112.889 -175.092 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 4.8 p -74.78 -38.16 43.83 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.13 0 C-N-CA 125.584 1.554 . . . . 0.0 113.13 -176.959 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 170.93 -83.47 0.08 OUTLIER Glycine 0 N--CA 1.47 0.921 0 C-N-CA 124.967 1.27 . . . . 0.0 112.803 -175.74 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 6.4 mt-30 . . . . . 0 N--CA 1.48 1.053 0 C-N-CA 129.098 2.959 . . . . 0.0 109.672 -179.7 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 41.9 p-90 . . . . . 0 CA--C 1.544 0.743 0 N-CA-C 112.229 0.455 . . . . 0.0 112.229 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 4.6 mtmt -147.5 23.32 1.14 Allowed 'General case' 0 CA--C 1.557 1.221 0 C-N-CA 127.991 2.516 . . . . 0.0 111.075 -174.668 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -49.73 139.99 12.13 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 124.703 1.201 . . . . 0.0 113.928 -168.907 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 11.8 p30 -74.0 -18.24 60.88 Favored 'General case' 0 CA--C 1.547 0.841 0 N-CA-C 113.695 0.998 . . . . 0.0 113.695 -178.75 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 21.2 m -72.27 154.33 92.07 Favored Pre-proline 0 CA--C 1.548 0.892 0 C-N-CA 124.864 1.265 . . . . 0.0 112.915 177.9 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -75.89 -15.48 18.81 Favored 'Trans proline' 0 CA--C 1.541 0.825 0 C-N-CA 123.445 2.763 . . . . 0.0 112.789 169.66 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 51.94 19.89 1.09 Allowed 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 129.241 3.016 . . . . 0.0 116.204 173.491 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . 0.273 12.0 p30 51.29 37.77 19.63 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 129.278 3.031 . . . . 0.0 113.539 -173.241 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 6.9 p -67.77 -26.78 35.89 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.183 0 N-CA-C 113.309 0.855 . . . . 0.0 113.309 -179.611 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 71.0 m . . . . . 0 C--O 1.252 1.228 0 C-N-CA 126.955 2.102 . . . . 0.0 113.13 176.008 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 19.0 pttp . . . . . 0 N--CA 1.484 1.266 0 N-CA-C 113.077 0.769 . . . . 0.0 113.077 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -139.3 -46.19 0.46 Allowed 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 114.449 1.277 . . . . 0.0 114.449 -171.881 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 77.34 25.08 64.29 Favored Glycine 0 CA--C 1.54 1.614 0 C-N-CA 123.93 0.776 . . . . 0.0 114.212 -173.823 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.1 m -156.49 -39.41 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 C-N-CA 126.677 1.991 . . . . 0.0 113.153 -172.748 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 118.46 62.05 0.29 Allowed Glycine 0 N--CA 1.474 1.174 0 C-N-CA 125.077 1.322 . . . . 0.0 112.922 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 37.9 mt-30 . . . . . 0 CA--C 1.553 1.077 0 C-N-CA 125.942 1.697 . . . . 0.0 113.707 176.393 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 10' ' ' TRP . . . . . 0.473 ' CZ3' ' HE3' ' A' ' 11' ' ' LYS . 46.6 p-90 . . . . . 0 CA--C 1.547 0.827 0 CA-C-O 121.22 0.533 . . . . 0.0 111.102 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.473 ' HE3' ' CZ3' ' A' ' 10' ' ' TRP . 15.6 mtmt -43.89 -53.79 5.8 Favored 'General case' 0 CA--C 1.557 1.249 0 C-N-CA 127.001 2.121 . . . . 0.0 113.502 -178.052 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 59.71 -67.72 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 130.131 3.372 . . . . 0.0 115.138 172.088 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 14.5 m-80 72.02 26.29 2.89 Favored 'General case' 0 CA--C 1.55 0.978 0 C-N-CA 126.457 1.903 . . . . 0.0 112.861 173.142 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 16.3 m -61.02 148.25 84.56 Favored Pre-proline 0 CA--C 1.548 0.884 0 C-N-CA 124.929 1.292 . . . . 0.0 114.22 -172.345 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -77.47 -18.06 14.1 Favored 'Trans proline' 0 CA--C 1.541 0.837 0 C-N-CA 123.551 2.834 . . . . 0.0 112.959 170.238 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 51.18 16.61 0.39 Allowed 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 129.407 3.083 . . . . 0.0 116.757 176.076 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 74.84 34.17 0.72 Allowed 'General case' 0 CA--C 1.553 1.068 0 C-N-CA 129.135 2.974 . . . . 0.0 113.013 177.484 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 40.8 t -55.23 -41.13 59.31 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.333 0 C-N-CA 124.094 0.958 . . . . 0.0 111.902 173.225 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 10.7 t . . . . . 0 C--O 1.254 1.333 0 C-N-CA 124.796 1.238 . . . . 0.0 111.63 173.459 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 36.0 tptt . . . . . 0 N--CA 1.479 1.01 0 N-CA-C 112.694 0.627 . . . . 0.0 112.694 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -157.79 124.36 4.88 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 125.829 1.652 . . . . 0.0 111.095 179.876 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -68.23 -15.77 68.15 Favored Glycine 0 N--CA 1.479 1.509 0 C-N-CA 124.454 1.026 . . . . 0.0 114.759 -175.972 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 19.8 t -64.77 -22.21 30.9 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 C-N-CA 125.448 1.499 . . . . 0.0 111.897 170.39 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 98.88 31.89 6.12 Favored Glycine 0 CA--C 1.537 1.419 0 C-N-CA 124.746 1.165 . . . . 0.0 113.364 -170.73 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 41.3 mt-30 . . . . . 0 CA--C 1.544 0.746 0 C-N-CA 126.527 1.931 . . . . 0.0 113.133 178.479 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 10' ' ' TRP . . . . . 0.459 ' CZ3' ' HE3' ' A' ' 11' ' ' LYS . 57.6 p-90 . . . . . 0 CA--C 1.548 0.902 0 N-CA-C 108.447 -0.945 . . . . 0.0 108.447 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.466 ' H ' ' HG3' ' A' ' 11' ' ' LYS . 13.6 mtmt -50.35 -44.66 54.61 Favored 'General case' 0 CA--C 1.554 1.117 0 C-N-CA 125.509 1.523 . . . . 0.0 112.914 176.414 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 16.7 mm-40 58.02 -171.51 0.1 Allowed 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 128.212 2.605 . . . . 0.0 113.285 173.257 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 12.8 p30 -76.53 -16.98 59.49 Favored 'General case' 0 CA--C 1.551 0.989 0 O-C-N 120.998 -1.063 . . . . 0.0 113.267 174.081 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 15.4 m -73.66 157.34 87.68 Favored Pre-proline 0 CA--C 1.546 0.812 0 C-N-CA 125.133 1.373 . . . . 0.0 113.336 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -75.89 -19.19 16.26 Favored 'Trans proline' 0 CA--C 1.541 0.852 0 C-N-CA 122.842 2.362 . . . . 0.0 111.761 169.029 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 55.23 11.92 0.61 Allowed 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 129.311 3.044 . . . . 0.0 116.099 174.807 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 69.37 29.86 4.34 Favored 'General case' 0 CA--C 1.553 1.059 0 C-N-CA 128.775 2.83 . . . . 0.0 112.64 -175.224 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 5.0 p -66.53 -24.45 33.12 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.167 0 N-CA-C 113.789 1.033 . . . . 0.0 113.789 -177.054 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 41.1 m . . . . . 0 C--O 1.254 1.325 0 C-N-CA 125.881 1.672 . . . . 0.0 113.949 -177.782 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 75.8 m . . . . . 0 N--CA 1.494 1.768 0 CA-C-O 119.79 -0.147 . . . . 0.0 111.117 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 9.7 mmm180 60.21 -98.45 0.08 Allowed 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 126.248 1.819 . . . . 0.0 110.72 176.756 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -140.61 20.74 2.36 Favored 'General case' 0 CA--C 1.552 1.03 0 C-N-CA 125.597 1.559 . . . . 0.0 112.406 176.599 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -143.96 102.73 3.93 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.68 1.192 . . . . 0.0 111.926 -174.837 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -70.45 -18.58 75.47 Favored Glycine 0 N--CA 1.477 1.376 0 C-N-CA 124.418 1.009 . . . . 0.0 114.517 -179.324 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.0 t -72.03 -16.28 18.5 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.184 0 C-N-CA 124.882 1.273 . . . . 0.0 112.008 173.758 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 96.34 40.94 3.82 Favored Glycine 0 CA--C 1.534 1.277 0 C-N-CA 124.414 1.007 . . . . 0.0 113.535 -175.526 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 62.17 55.75 2.37 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 125.767 1.627 . . . . 0.0 111.724 -177.49 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 10' ' ' TRP . . . . . 0.405 ' CE2' ' HG2' ' A' ' 12' ' ' GLU . 30.8 p-90 -156.8 -77.7 0.09 Allowed 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.856 1.662 . . . . 0.0 111.832 -177.068 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 5.3 mtmt -149.97 22.89 0.87 Allowed 'General case' 0 CA--C 1.557 1.222 0 C-N-CA 128.011 2.525 . . . . 0.0 111.1 -176.178 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.405 ' HG2' ' CE2' ' A' ' 10' ' ' TRP . 21.4 mt-10 -52.13 140.95 19.66 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 124.357 1.063 . . . . 0.0 113.485 -169.0 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 67.9 m-80 -76.84 -25.89 53.7 Favored 'General case' 0 CA--C 1.545 0.758 0 N-CA-C 113.55 0.944 . . . . 0.0 113.55 -173.331 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 27.6 m -73.52 151.85 89.55 Favored Pre-proline 0 CA--C 1.547 0.859 0 C-N-CA 123.92 0.888 . . . . 0.0 112.465 176.656 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -73.77 -18.1 22.34 Favored 'Trans proline' 0 CA--C 1.539 0.766 0 C-N-CA 122.988 2.459 . . . . 0.0 112.703 169.793 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 53.35 14.17 0.51 Allowed 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 129.67 3.188 . . . . 0.0 116.43 173.443 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 74.32 38.45 0.53 Allowed 'General case' 0 CA--C 1.552 1.055 0 C-N-CA 129.099 2.96 . . . . 0.0 112.908 178.741 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 36.2 t -57.31 -33.73 44.33 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 C-N-CA 124.372 1.069 . . . . 0.0 112.435 172.25 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 10.8 t . . . . . 0 C--O 1.255 1.378 0 C-N-CA 125.144 1.378 . . . . 0.0 113.32 179.809 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 35.9 t . . . . . 0 N--CA 1.491 1.603 0 CA-C-O 119.491 -0.29 . . . . 0.0 110.477 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -164.7 -49.64 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 124.73 1.212 . . . . 0.0 112.912 178.435 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 84.1 mttt 60.78 73.29 0.49 Allowed 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 126.638 1.975 . . . . 0.0 112.66 173.854 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -62.78 -26.77 68.88 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 125.421 1.488 . . . . 0.0 114.718 -172.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 77.74 -46.12 2.55 Favored Glycine 0 N--CA 1.478 1.455 0 C-N-CA 125.564 1.554 . . . . 0.0 114.031 176.417 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 4.1 m -60.7 -30.52 47.17 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.296 0 C-N-CA 125.032 1.333 . . . . 0.0 114.089 175.974 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 132.61 24.85 0.73 Allowed Glycine 0 N--CA 1.476 1.336 0 C-N-CA 125.503 1.525 . . . . 0.0 115.63 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 11.8 mt-30 63.41 44.31 5.5 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 125.697 1.599 . . . . 0.0 111.616 -179.291 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 38.3 p-90 -147.74 -79.37 0.15 Allowed 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 126.084 1.754 . . . . 0.0 111.794 179.458 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 6.0 mtmt -151.77 22.53 0.69 Allowed 'General case' 0 CA--C 1.556 1.173 0 C-N-CA 127.746 2.419 . . . . 0.0 111.672 -174.173 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 21.4 mt-10 -51.54 141.03 16.88 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 124.268 1.027 . . . . 0.0 113.753 -169.149 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 68.3 m-80 -81.85 -21.95 37.25 Favored 'General case' 0 CA--C 1.546 0.801 0 N-CA-C 113.625 0.972 . . . . 0.0 113.625 -174.907 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 22.8 m -71.86 152.76 93.16 Favored Pre-proline 0 N--CA 1.475 0.784 0 O-C-N 121.174 -0.954 . . . . 0.0 112.578 176.935 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -74.06 -17.59 21.99 Favored 'Trans proline' 0 CA--C 1.539 0.764 0 C-N-CA 123.002 2.468 . . . . 0.0 112.441 169.663 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 53.19 13.92 0.45 Allowed 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 129.664 3.186 . . . . 0.0 116.371 174.428 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 74.79 35.15 0.66 Allowed 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 129.136 2.974 . . . . 0.0 113.121 178.613 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 28.0 t -51.26 -44.06 29.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 C-N-CA 124.474 1.11 . . . . 0.0 111.646 174.057 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 5.6 t . . . . . 0 C--O 1.254 1.313 0 C-N-CA 127.273 2.229 . . . . 0.0 112.887 172.775 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 31.8 p . . . . . 0 N--CA 1.493 1.699 0 N-CA-C 111.442 0.164 . . . . 0.0 111.442 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 27.2 ptt-85 -63.07 143.61 57.63 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 124.007 0.923 . . . . 0.0 113.037 -178.645 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 14.4 tmtt? -168.32 103.95 0.45 Allowed 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 126.674 1.99 . . . . 0.0 110.291 -179.18 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.445 ' HB3' ' H ' ' A' ' 8' ' ' GLN . . . -89.96 139.31 30.73 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 125.173 1.389 . . . . 0.0 111.227 173.658 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -79.13 43.26 2.45 Favored Glycine 0 N--CA 1.476 1.306 0 C-N-CA 125.167 1.365 . . . . 0.0 114.602 -176.078 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 5.6 p -168.83 -50.41 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.262 0 C-N-CA 125.566 1.547 . . . . 0.0 112.657 -177.481 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 145.54 52.6 0.03 OUTLIER Glycine 0 N--CA 1.477 1.392 0 C-N-CA 124.417 1.008 . . . . 0.0 114.906 -178.903 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.445 ' H ' ' HB3' ' A' ' 4' ' ' ALA . 31.6 mt-30 61.03 42.68 12.29 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 126.049 1.74 . . . . 0.0 112.85 176.212 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 34.3 p-90 -147.49 -80.59 0.14 Allowed 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 125.41 1.484 . . . . 0.0 112.272 -178.695 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 6.8 mtmt -146.91 24.52 1.18 Allowed 'General case' 0 CA--C 1.555 1.17 0 C-N-CA 128.067 2.547 . . . . 0.0 110.877 -175.821 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -54.6 139.0 39.79 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 124.048 0.939 . . . . 0.0 112.497 -169.259 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 9.4 p30 -149.44 17.37 0.92 Allowed 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 124.54 1.136 . . . . 0.0 113.405 -171.913 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 18.6 m -70.22 154.63 94.4 Favored Pre-proline 0 CA--C 1.549 0.926 0 C-N-CA 125.1 1.36 . . . . 0.0 113.497 -175.755 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -73.75 -14.66 24.32 Favored 'Trans proline' 0 C--N 1.356 0.922 0 C-N-CA 123.618 2.879 . . . . 0.0 113.372 171.206 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . 0.275 1.8 pp 58.87 4.45 0.4 Allowed 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 130.368 3.467 . . . . 0.0 117.039 169.555 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 29.2 m120 77.5 47.0 0.06 Allowed 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 129.8 3.24 . . . . 0.0 111.789 177.224 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 56.0 t -62.93 -29.57 47.49 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.213 0 C-N-CA 124.361 1.065 . . . . 0.0 111.402 169.916 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 11.7 p . . . . . 0 C--O 1.253 1.275 0 C-N-CA 126.194 1.798 . . . . 0.0 114.654 175.6 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 47.0 t . . . . . 0 N--CA 1.49 1.574 0 CA-C-O 119.729 -0.177 . . . . 0.0 110.764 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 87.7 mtt-85 -139.16 110.02 6.75 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 125.182 1.393 . . . . 0.0 110.606 171.109 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 54.0 mtmt -112.27 74.05 0.85 Allowed 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 126.428 1.891 . . . . 0.0 108.71 171.288 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -13.97 96.25 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 128.987 2.915 . . . . 0.0 115.244 -169.602 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -67.26 -28.18 73.65 Favored Glycine 0 N--CA 1.479 1.524 0 C-N-CA 123.847 0.737 . . . . 0.0 113.796 -171.789 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.8 m -61.41 -27.56 42.18 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.158 0 C-N-CA 125.157 1.383 . . . . 0.0 113.286 169.542 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 137.63 123.91 2.24 Favored Glycine 0 CA--C 1.528 0.871 0 C-N-CA 128.011 2.719 . . . . 0.0 109.36 -172.648 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 32.9 mt-30 -72.95 65.67 0.75 Allowed 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 125.293 1.437 . . . . 0.0 111.145 171.677 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 10' ' ' TRP . . . . . 0.482 ' CZ3' ' HE3' ' A' ' 11' ' ' LYS . 30.2 p-90 -49.35 -64.89 0.67 Allowed 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 126.929 2.092 . . . . 0.0 114.242 179.635 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.482 ' HE3' ' CZ3' ' A' ' 10' ' ' TRP . 27.9 mtmt -145.3 -62.05 0.34 Allowed 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 126.457 1.903 . . . . 0.0 109.034 176.512 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 62.54 171.71 0.14 Allowed 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 128.751 2.82 . . . . 0.0 113.191 178.291 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 69.0 m-80 -112.31 0.87 15.85 Favored 'General case' 0 CA--C 1.549 0.918 0 N-CA-C 114.034 1.124 . . . . 0.0 114.034 -176.244 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 15.8 m -69.76 150.19 96.62 Favored Pre-proline 0 N--CA 1.475 0.823 0 O-C-N 120.712 -1.243 . . . . 0.0 113.614 -175.711 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -76.34 -16.19 17.47 Favored 'Trans proline' 0 CA--C 1.541 0.83 0 C-N-CA 123.33 2.687 . . . . 0.0 112.136 169.383 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 54.17 14.35 0.72 Allowed 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 129.69 3.196 . . . . 0.0 116.498 175.038 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 78.77 33.25 0.27 Allowed 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 129.343 3.057 . . . . 0.0 113.235 172.486 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 47.3 t -56.5 -32.57 36.84 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.381 0 C-N-CA 124.745 1.218 . . . . 0.0 112.251 175.152 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 77.7 p . . . . . 0 C--O 1.253 1.239 0 C-N-CA 125.935 1.694 . . . . 0.0 113.468 179.425 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 80.5 m . . . . . 0 N--CA 1.492 1.66 0 CA-C-O 118.898 -0.572 . . . . 0.0 111.04 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 12.7 ptp180 -153.65 145.4 23.42 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 125.245 1.418 . . . . 0.0 112.187 178.823 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 4.4 tmtm? -162.9 44.36 0.13 Allowed 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 125.021 1.328 . . . . 0.0 112.209 -173.735 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -169.8 151.75 4.3 Favored 'General case' 0 N--CA 1.481 1.075 0 C-N-CA 127.138 2.175 . . . . 0.0 111.232 -179.368 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -155.1 -46.8 0.02 OUTLIER Glycine 0 N--CA 1.479 1.518 0 C-N-CA 124.984 1.278 . . . . 0.0 114.643 -179.591 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.4 t -41.48 -56.49 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 C-N-CA 126.812 2.045 . . . . 0.0 113.379 177.109 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -140.52 -18.0 0.41 Allowed Glycine 0 N--CA 1.477 1.393 0 C-N-CA 124.244 0.926 . . . . 0.0 115.382 177.821 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 99.1 mt-30 56.43 45.83 21.9 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 125.821 1.648 . . . . 0.0 113.368 177.103 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 49.3 p-90 -76.67 -95.26 0.02 OUTLIER 'General case' 0 CA--C 1.546 0.794 0 O-C-N 121.214 -0.929 . . . . 0.0 112.776 -170.601 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 22.1 mtmt -115.22 -23.78 8.79 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 127.196 2.198 . . . . 0.0 111.252 175.108 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 19.26 -88.76 0.0 OUTLIER 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 131.32 3.848 . . . . 0.0 114.623 -175.142 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 69.1 m-80 -130.28 23.27 5.19 Favored 'General case' 0 CA--C 1.553 1.059 0 C-N-CA 126.933 2.093 . . . . 0.0 111.93 179.294 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 35.3 m -114.93 154.08 47.03 Favored Pre-proline 0 N--CA 1.476 0.837 0 C-N-CA 125.284 1.433 . . . . 0.0 113.251 -169.76 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -78.28 -15.81 14.1 Favored 'Trans proline' 0 CA--C 1.541 0.837 0 C-N-CA 123.311 2.674 . . . . 0.0 112.304 169.288 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 52.25 15.52 0.47 Allowed 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 129.406 3.083 . . . . 0.0 116.38 177.063 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 72.2 26.59 2.72 Favored 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 129.309 3.044 . . . . 0.0 112.715 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 5.3 p -65.75 -25.97 37.7 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.241 0 C-N-CA 124.251 1.02 . . . . 0.0 113.675 -175.091 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 11.2 t . . . . . 0 C--O 1.256 1.419 0 C-N-CA 125.608 1.563 . . . . 0.0 111.63 175.935 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 27.6 p . . . . . 0 N--CA 1.491 1.604 0 CA-C-O 119.596 -0.24 . . . . 0.0 111.616 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 9.3 mtt85 172.03 163.44 0.1 Allowed 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 129.018 2.927 . . . . 0.0 111.555 176.848 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 38.2 pttt -137.07 -68.51 0.48 Allowed 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 125.678 1.591 . . . . 0.0 111.19 178.428 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.437 ' HB2' ' CD1' ' A' ' 10' ' ' TRP . . . -155.79 151.08 26.79 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 126.067 1.747 . . . . 0.0 109.989 169.394 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -71.19 -37.09 63.67 Favored Glycine 0 N--CA 1.478 1.483 0 C-N-CA 123.397 0.522 . . . . 0.0 112.59 179.512 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.5 m -64.75 -32.32 57.51 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.223 0 C-N-CA 124.912 1.285 . . . . 0.0 112.99 169.859 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 133.39 -77.03 0.39 Allowed Glycine 0 N--CA 1.469 0.854 0 C-N-CA 126.576 2.036 . . . . 0.0 111.929 177.951 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 16.1 mp0 -140.75 14.68 2.31 Favored 'General case' 0 CA--C 1.555 1.143 0 C-N-CA 124.918 1.287 . . . . 0.0 112.546 -173.498 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 10' ' ' TRP . . . . . 0.448 ' CZ3' ' HE3' ' A' ' 11' ' ' LYS . 32.7 p-90 -161.55 -164.28 1.1 Allowed 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 126.747 2.019 . . . . 0.0 112.869 -178.492 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.448 ' HE3' ' CZ3' ' A' ' 10' ' ' TRP . 14.8 mtmt -46.16 -42.97 14.67 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 127.739 2.416 . . . . 0.0 114.62 -177.638 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 29.89 -99.09 0.01 OUTLIER 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 129.074 2.95 . . . . 0.0 114.134 -170.371 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -162.68 35.3 0.11 Allowed 'General case' 0 CA--C 1.55 0.972 0 C-N-CA 126.642 1.977 . . . . 0.0 111.676 -169.606 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 44.7 m -133.23 152.4 79.41 Favored Pre-proline 0 N--CA 1.478 0.958 0 C-N-CA 124.299 1.04 . . . . 0.0 112.79 -172.528 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -77.94 -16.78 14.14 Favored 'Trans proline' 0 C--N 1.354 0.821 0 C-N-CA 123.556 2.837 . . . . 0.0 112.792 169.783 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 50.62 17.11 0.35 Allowed 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 129.603 3.161 . . . . 0.0 116.54 176.907 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 77.04 32.2 0.49 Allowed 'General case' 0 CA--C 1.551 1.019 0 C-N-CA 129.549 3.14 . . . . 0.0 113.375 174.895 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 42.8 t -56.03 -33.64 36.4 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 C-N-CA 124.513 1.125 . . . . 0.0 112.291 174.26 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 77.5 p . . . . . 0 C--O 1.252 1.233 0 C-N-CA 125.949 1.699 . . . . 0.0 113.372 179.467 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 78.3 m . . . . . 0 N--CA 1.493 1.698 0 CA-C-O 119.739 -0.172 . . . . 0.0 111.207 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 57.4 mtm180 54.23 41.24 32.09 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 125.801 1.64 . . . . 0.0 113.719 174.759 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 55.2 tttp -78.67 -52.86 7.83 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 124.364 1.066 . . . . 0.0 112.797 -173.641 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -94.92 -32.31 13.27 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 124.65 1.18 . . . . 0.0 113.481 178.188 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 72.64 19.82 79.33 Favored Glycine 0 CA--C 1.537 1.43 0 C-N-CA 124.127 0.87 . . . . 0.0 114.185 -173.457 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 48.4 t -149.95 -68.64 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 C-N-CA 126.48 1.912 . . . . 0.0 109.21 -172.506 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 158.46 42.21 0.02 OUTLIER Glycine 0 CA--C 1.536 1.353 0 C-N-CA 125.316 1.436 . . . . 0.0 113.41 -178.406 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 40.5 mt-30 55.8 39.21 30.73 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 126.043 1.737 . . . . 0.0 112.099 -169.751 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 10' ' ' TRP . . . . . 0.43 ' CZ3' ' HE3' ' A' ' 11' ' ' LYS . 51.0 p-90 -165.9 -156.6 0.27 Allowed 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 128.29 2.636 . . . . 0.0 110.089 176.529 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.43 ' HE3' ' CZ3' ' A' ' 10' ' ' TRP . 13.7 mtmt -47.85 -39.99 20.1 Favored 'General case' 0 CA--C 1.552 1.046 0 C-N-CA 126.548 1.939 . . . . 0.0 113.808 178.553 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 19.4 mm-40 46.28 -104.54 0.1 Allowed 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 128.286 2.634 . . . . 0.0 112.016 175.762 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 5.3 p30 -176.88 -48.84 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 127.842 2.457 . . . . 0.0 110.328 174.212 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 21.2 m 71.92 156.82 0.16 Allowed Pre-proline 0 CA--C 1.551 1.019 0 C-N-CA 127.583 2.353 . . . . 0.0 113.744 172.941 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -76.86 -22.94 11.26 Favored 'Trans proline' 0 C--N 1.354 0.844 0 C-N-CA 122.926 2.417 . . . . 0.0 112.725 170.111 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 50.3 15.87 0.23 Allowed 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 129.496 3.118 . . . . 0.0 116.815 175.379 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 69.78 41.34 1.21 Allowed 'General case' 0 CA--C 1.553 1.065 0 C-N-CA 128.802 2.841 . . . . 0.0 113.083 -178.562 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 42.5 t -58.35 -33.99 49.11 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 C-N-CA 124.053 0.941 . . . . 0.0 112.356 170.337 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 76.2 p . . . . . 0 C--O 1.255 1.365 0 C-N-CA 126.923 2.089 . . . . 0.0 114.828 178.678 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 7.7 p . . . . . 0 N--CA 1.494 1.752 0 CA-C-O 121.143 0.497 . . . . 0.0 111.885 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.9 99.29 11.1 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 124.704 1.201 . . . . 0.0 110.818 -176.792 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 24.7 mtpp 48.79 37.86 10.69 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 126.263 1.825 . . . . 0.0 114.31 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . 112.22 -36.6 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.303 1 C-N-CA 132.031 4.132 . . . . 0.0 112.541 -179.066 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 73.48 -55.47 2.01 Favored Glycine 0 CA--C 1.532 1.118 0 C-N-CA 126.386 1.946 . . . . 0.0 112.889 -175.092 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 4.8 p -74.78 -38.16 43.83 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.13 0 C-N-CA 125.584 1.554 . . . . 0.0 113.13 -176.959 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 170.93 -83.47 0.08 OUTLIER Glycine 0 N--CA 1.47 0.921 0 C-N-CA 124.967 1.27 . . . . 0.0 112.803 -175.74 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 6.4 mt-30 -177.86 53.59 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 129.098 2.959 . . . . 0.0 109.672 -179.7 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 41.9 p-90 -151.54 -83.71 0.09 Allowed 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 125.565 1.546 . . . . 0.0 112.229 -175.026 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 4.6 mtmt -147.5 23.32 1.14 Allowed 'General case' 0 CA--C 1.557 1.221 0 C-N-CA 127.991 2.516 . . . . 0.0 111.075 -174.668 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -49.73 139.99 12.13 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 124.703 1.201 . . . . 0.0 113.928 -168.907 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 11.8 p30 -74.0 -18.24 60.88 Favored 'General case' 0 CA--C 1.547 0.841 0 N-CA-C 113.695 0.998 . . . . 0.0 113.695 -178.75 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 21.2 m -72.27 154.33 92.07 Favored Pre-proline 0 CA--C 1.548 0.892 0 C-N-CA 124.864 1.265 . . . . 0.0 112.915 177.9 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -75.89 -15.48 18.81 Favored 'Trans proline' 0 CA--C 1.541 0.825 0 C-N-CA 123.445 2.763 . . . . 0.0 112.789 169.66 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 51.94 19.89 1.09 Allowed 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 129.241 3.016 . . . . 0.0 116.204 173.491 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . 0.273 12.0 p30 51.29 37.77 19.63 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 129.278 3.031 . . . . 0.0 113.539 -173.241 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 6.9 p -67.77 -26.78 35.89 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.183 0 N-CA-C 113.309 0.855 . . . . 0.0 113.309 -179.611 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 71.0 m . . . . . 0 C--O 1.252 1.228 0 C-N-CA 126.955 2.102 . . . . 0.0 113.13 176.008 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 85.6 m . . . . . 0 N--CA 1.493 1.703 0 CA-C-O 118.932 -0.556 . . . . 0.0 112.209 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -75.59 124.3 26.98 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 124.981 1.312 . . . . 0.0 113.022 -174.4 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 19.0 pttp -167.2 34.1 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 126.799 2.04 . . . . 0.0 113.077 -175.793 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -139.3 -46.19 0.46 Allowed 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 114.449 1.277 . . . . 0.0 114.449 -171.881 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 77.34 25.08 64.29 Favored Glycine 0 CA--C 1.54 1.614 0 C-N-CA 123.93 0.776 . . . . 0.0 114.212 -173.823 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.1 m -156.49 -39.41 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 C-N-CA 126.677 1.991 . . . . 0.0 113.153 -172.748 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 118.46 62.05 0.29 Allowed Glycine 0 N--CA 1.474 1.174 0 C-N-CA 125.077 1.322 . . . . 0.0 112.922 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 37.9 mt-30 62.19 33.86 16.52 Favored 'General case' 0 CA--C 1.553 1.077 0 C-N-CA 125.942 1.697 . . . . 0.0 113.707 176.393 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 10' ' ' TRP . . . . . 0.473 ' CZ3' ' HE3' ' A' ' 11' ' ' LYS . 46.6 p-90 -163.08 -162.25 0.75 Allowed 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 127.641 2.376 . . . . 0.0 111.102 176.075 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.473 ' HE3' ' CZ3' ' A' ' 10' ' ' TRP . 15.6 mtmt -43.89 -53.79 5.8 Favored 'General case' 0 CA--C 1.557 1.249 0 C-N-CA 127.001 2.121 . . . . 0.0 113.502 -178.052 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 59.71 -67.72 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 130.131 3.372 . . . . 0.0 115.138 172.088 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 14.5 m-80 72.02 26.29 2.89 Favored 'General case' 0 CA--C 1.55 0.978 0 C-N-CA 126.457 1.903 . . . . 0.0 112.861 173.142 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 16.3 m -61.02 148.25 84.56 Favored Pre-proline 0 CA--C 1.548 0.884 0 C-N-CA 124.929 1.292 . . . . 0.0 114.22 -172.345 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -77.47 -18.06 14.1 Favored 'Trans proline' 0 CA--C 1.541 0.837 0 C-N-CA 123.551 2.834 . . . . 0.0 112.959 170.238 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 51.18 16.61 0.39 Allowed 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 129.407 3.083 . . . . 0.0 116.757 176.076 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 74.84 34.17 0.72 Allowed 'General case' 0 CA--C 1.553 1.068 0 C-N-CA 129.135 2.974 . . . . 0.0 113.013 177.484 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 40.8 t -55.23 -41.13 59.31 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.333 0 C-N-CA 124.094 0.958 . . . . 0.0 111.902 173.225 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 10.7 t . . . . . 0 C--O 1.254 1.333 0 C-N-CA 124.796 1.238 . . . . 0.0 111.63 173.459 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 87.7 m . . . . . 0 N--CA 1.492 1.63 0 CA-C-O 119.064 -0.494 . . . . 0.0 111.907 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 4.2 ppt_? -60.16 138.58 57.88 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 124.127 0.971 . . . . 0.0 113.556 -174.338 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 36.0 tptt -168.34 -45.78 0.02 OUTLIER 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 125.662 1.585 . . . . 0.0 112.694 179.616 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -157.79 124.36 4.88 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 125.829 1.652 . . . . 0.0 111.095 179.876 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -68.23 -15.77 68.15 Favored Glycine 0 N--CA 1.479 1.509 0 C-N-CA 124.454 1.026 . . . . 0.0 114.759 -175.972 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 19.8 t -64.77 -22.21 30.9 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 C-N-CA 125.448 1.499 . . . . 0.0 111.897 170.39 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 98.88 31.89 6.12 Favored Glycine 0 CA--C 1.537 1.419 0 C-N-CA 124.746 1.165 . . . . 0.0 113.364 -170.73 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 41.3 mt-30 66.48 60.81 0.58 Allowed 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 126.527 1.931 . . . . 0.0 113.133 178.479 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 10' ' ' TRP . . . . . 0.459 ' CZ3' ' HE3' ' A' ' 11' ' ' LYS . 57.6 p-90 -169.33 -153.43 0.11 Allowed 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 130.028 3.331 . . . . 0.0 108.447 178.865 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.466 ' H ' ' HG3' ' A' ' 11' ' ' LYS . 13.6 mtmt -50.35 -44.66 54.61 Favored 'General case' 0 CA--C 1.554 1.117 0 C-N-CA 125.509 1.523 . . . . 0.0 112.914 176.414 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 16.7 mm-40 58.02 -171.51 0.1 Allowed 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 128.212 2.605 . . . . 0.0 113.285 173.257 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 12.8 p30 -76.53 -16.98 59.49 Favored 'General case' 0 CA--C 1.551 0.989 0 O-C-N 120.998 -1.063 . . . . 0.0 113.267 174.081 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 15.4 m -73.66 157.34 87.68 Favored Pre-proline 0 CA--C 1.546 0.812 0 C-N-CA 125.133 1.373 . . . . 0.0 113.336 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -75.89 -19.19 16.26 Favored 'Trans proline' 0 CA--C 1.541 0.852 0 C-N-CA 122.842 2.362 . . . . 0.0 111.761 169.029 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 55.23 11.92 0.61 Allowed 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 129.311 3.044 . . . . 0.0 116.099 174.807 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 69.37 29.86 4.34 Favored 'General case' 0 CA--C 1.553 1.059 0 C-N-CA 128.775 2.83 . . . . 0.0 112.64 -175.224 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 5.0 p -66.53 -24.45 33.12 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.167 0 N-CA-C 113.789 1.033 . . . . 0.0 113.789 -177.054 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 41.1 m . . . . . 0 C--O 1.254 1.325 0 C-N-CA 125.881 1.672 . . . . 0.0 113.949 -177.782 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 CA--C 1.552 1.03 0 N-CA-C 112.406 0.521 . . . . 0.0 112.406 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -143.96 102.73 3.93 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.68 1.192 . . . . 0.0 111.926 -174.837 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -70.45 -18.58 75.47 Favored Glycine 0 N--CA 1.477 1.376 0 C-N-CA 124.418 1.009 . . . . 0.0 114.517 -179.324 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.0 t -72.03 -16.28 18.5 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.184 0 C-N-CA 124.882 1.273 . . . . 0.0 112.008 173.758 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 96.34 40.94 3.82 Favored Glycine 0 CA--C 1.534 1.277 0 C-N-CA 124.414 1.007 . . . . 0.0 113.535 -175.526 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 . . . . . 0 N--CA 1.477 0.918 0 C-N-CA 125.767 1.627 . . . . 0.0 111.724 -177.49 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . 0.405 ' CE2' ' HG2' ' A' ' 12' ' ' GLU . 30.8 p-90 . . . . . 0 CA--C 1.543 0.674 0 CA-C-O 120.89 0.376 . . . . 0.0 111.832 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 5.3 mtmt -149.97 22.89 0.87 Allowed 'General case' 0 CA--C 1.557 1.222 0 C-N-CA 128.011 2.525 . . . . 0.0 111.1 -176.178 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.405 ' HG2' ' CE2' ' A' ' 10' ' ' TRP . 21.4 mt-10 -52.13 140.95 19.66 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 124.357 1.063 . . . . 0.0 113.485 -169.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 67.9 m-80 -76.84 -25.89 53.7 Favored 'General case' 0 CA--C 1.545 0.758 0 N-CA-C 113.55 0.944 . . . . 0.0 113.55 -173.331 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 27.6 m -73.52 151.85 89.55 Favored Pre-proline 0 CA--C 1.547 0.859 0 C-N-CA 123.92 0.888 . . . . 0.0 112.465 176.656 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -73.77 -18.1 22.34 Favored 'Trans proline' 0 CA--C 1.539 0.766 0 C-N-CA 122.988 2.459 . . . . 0.0 112.703 169.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 53.35 14.17 0.51 Allowed 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 129.67 3.188 . . . . 0.0 116.43 173.443 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 74.32 38.45 0.53 Allowed 'General case' 0 CA--C 1.552 1.055 0 C-N-CA 129.099 2.96 . . . . 0.0 112.908 178.741 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 36.2 t -57.31 -33.73 44.33 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 C-N-CA 124.372 1.069 . . . . 0.0 112.435 172.25 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 10.8 t . . . . . 0 C--O 1.255 1.378 0 C-N-CA 125.144 1.378 . . . . 0.0 113.32 179.809 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 84.1 mttt . . . . . 0 N--CA 1.48 1.057 0 CA-C-O 121.872 0.844 . . . . 0.0 112.66 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -62.78 -26.77 68.88 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 125.421 1.488 . . . . 0.0 114.718 -172.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 77.74 -46.12 2.55 Favored Glycine 0 N--CA 1.478 1.455 0 C-N-CA 125.564 1.554 . . . . 0.0 114.031 176.417 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 4.1 m -60.7 -30.52 47.17 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.296 0 C-N-CA 125.032 1.333 . . . . 0.0 114.089 175.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 132.61 24.85 0.73 Allowed Glycine 0 N--CA 1.476 1.336 0 C-N-CA 125.503 1.525 . . . . 0.0 115.63 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 11.8 mt-30 . . . . . 0 N--CA 1.479 0.978 0 C-N-CA 125.697 1.599 . . . . 0.0 111.616 -179.291 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 38.3 p-90 . . . . . 0 CA--C 1.543 0.675 0 N-CA-C 111.794 0.294 . . . . 0.0 111.794 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 6.0 mtmt -151.77 22.53 0.69 Allowed 'General case' 0 CA--C 1.556 1.173 0 C-N-CA 127.746 2.419 . . . . 0.0 111.672 -174.173 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 21.4 mt-10 -51.54 141.03 16.88 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 124.268 1.027 . . . . 0.0 113.753 -169.149 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 68.3 m-80 -81.85 -21.95 37.25 Favored 'General case' 0 CA--C 1.546 0.801 0 N-CA-C 113.625 0.972 . . . . 0.0 113.625 -174.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 22.8 m -71.86 152.76 93.16 Favored Pre-proline 0 N--CA 1.475 0.784 0 O-C-N 121.174 -0.954 . . . . 0.0 112.578 176.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -74.06 -17.59 21.99 Favored 'Trans proline' 0 CA--C 1.539 0.764 0 C-N-CA 123.002 2.468 . . . . 0.0 112.441 169.663 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 53.19 13.92 0.45 Allowed 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 129.664 3.186 . . . . 0.0 116.371 174.428 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 74.79 35.15 0.66 Allowed 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 129.136 2.974 . . . . 0.0 113.121 178.613 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 28.0 t -51.26 -44.06 29.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 C-N-CA 124.474 1.11 . . . . 0.0 111.646 174.057 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 5.6 t . . . . . 0 C--O 1.254 1.313 0 C-N-CA 127.273 2.229 . . . . 0.0 112.887 172.775 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 14.4 tmtt? . . . . . 0 N--CA 1.474 0.747 0 CA-C-O 121.208 0.527 . . . . 0.0 110.291 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.445 ' HB3' ' H ' ' A' ' 8' ' ' GLN . . . -89.96 139.31 30.73 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 125.173 1.389 . . . . 0.0 111.227 173.658 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -79.13 43.26 2.45 Favored Glycine 0 N--CA 1.476 1.306 0 C-N-CA 125.167 1.365 . . . . 0.0 114.602 -176.078 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 5.6 p -168.83 -50.41 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.262 0 C-N-CA 125.566 1.547 . . . . 0.0 112.657 -177.481 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 145.54 52.6 0.03 OUTLIER Glycine 0 N--CA 1.477 1.392 0 C-N-CA 124.417 1.008 . . . . 0.0 114.906 -178.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . 0.445 ' H ' ' HB3' ' A' ' 4' ' ' ALA . 31.6 mt-30 . . . . . 0 N--CA 1.48 1.04 0 C-N-CA 126.049 1.74 . . . . 0.0 112.85 176.212 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 34.3 p-90 . . . . . 0 CA--C 1.545 0.757 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 6.8 mtmt -146.91 24.52 1.18 Allowed 'General case' 0 CA--C 1.555 1.17 0 C-N-CA 128.067 2.547 . . . . 0.0 110.877 -175.821 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -54.6 139.0 39.79 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 124.048 0.939 . . . . 0.0 112.497 -169.259 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 9.4 p30 -149.44 17.37 0.92 Allowed 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 124.54 1.136 . . . . 0.0 113.405 -171.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 18.6 m -70.22 154.63 94.4 Favored Pre-proline 0 CA--C 1.549 0.926 0 C-N-CA 125.1 1.36 . . . . 0.0 113.497 -175.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -73.75 -14.66 24.32 Favored 'Trans proline' 0 C--N 1.356 0.922 0 C-N-CA 123.618 2.879 . . . . 0.0 113.372 171.206 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . 0.275 1.8 pp 58.87 4.45 0.4 Allowed 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 130.368 3.467 . . . . 0.0 117.039 169.555 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 29.2 m120 77.5 47.0 0.06 Allowed 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 129.8 3.24 . . . . 0.0 111.789 177.224 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 56.0 t -62.93 -29.57 47.49 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.213 0 C-N-CA 124.361 1.065 . . . . 0.0 111.402 169.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 11.7 p . . . . . 0 C--O 1.253 1.275 0 C-N-CA 126.194 1.798 . . . . 0.0 114.654 175.6 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 54.0 mtmt . . . . . 0 CA--C 1.544 0.728 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -13.97 96.25 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 128.987 2.915 . . . . 0.0 115.244 -169.602 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -67.26 -28.18 73.65 Favored Glycine 0 N--CA 1.479 1.524 0 C-N-CA 123.847 0.737 . . . . 0.0 113.796 -171.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.8 m -61.41 -27.56 42.18 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.158 0 C-N-CA 125.157 1.383 . . . . 0.0 113.286 169.542 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 137.63 123.91 2.24 Favored Glycine 0 CA--C 1.528 0.871 0 C-N-CA 128.011 2.719 . . . . 0.0 109.36 -172.648 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 32.9 mt-30 . . . . . 0 N--CA 1.473 0.687 0 C-N-CA 125.293 1.437 . . . . 0.0 111.145 171.677 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . 0.482 ' CZ3' ' HE3' ' A' ' 11' ' ' LYS . 30.2 p-90 . . . . . 0 CA--C 1.542 0.66 0 N-CA-C 114.242 1.201 . . . . 0.0 114.242 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.482 ' HE3' ' CZ3' ' A' ' 10' ' ' TRP . 27.9 mtmt -145.3 -62.05 0.34 Allowed 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 126.457 1.903 . . . . 0.0 109.034 176.512 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 62.54 171.71 0.14 Allowed 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 128.751 2.82 . . . . 0.0 113.191 178.291 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 69.0 m-80 -112.31 0.87 15.85 Favored 'General case' 0 CA--C 1.549 0.918 0 N-CA-C 114.034 1.124 . . . . 0.0 114.034 -176.244 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 15.8 m -69.76 150.19 96.62 Favored Pre-proline 0 N--CA 1.475 0.823 0 O-C-N 120.712 -1.243 . . . . 0.0 113.614 -175.711 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -76.34 -16.19 17.47 Favored 'Trans proline' 0 CA--C 1.541 0.83 0 C-N-CA 123.33 2.687 . . . . 0.0 112.136 169.383 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 54.17 14.35 0.72 Allowed 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 129.69 3.196 . . . . 0.0 116.498 175.038 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 78.77 33.25 0.27 Allowed 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 129.343 3.057 . . . . 0.0 113.235 172.486 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 47.3 t -56.5 -32.57 36.84 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.381 0 C-N-CA 124.745 1.218 . . . . 0.0 112.251 175.152 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 77.7 p . . . . . 0 C--O 1.253 1.239 0 C-N-CA 125.935 1.694 . . . . 0.0 113.468 179.425 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 4.4 tmtm? . . . . . 0 N--CA 1.48 1.065 0 N-CA-C 112.209 0.448 . . . . 0.0 112.209 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -169.8 151.75 4.3 Favored 'General case' 0 N--CA 1.481 1.075 0 C-N-CA 127.138 2.175 . . . . 0.0 111.232 -179.368 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -155.1 -46.8 0.02 OUTLIER Glycine 0 N--CA 1.479 1.518 0 C-N-CA 124.984 1.278 . . . . 0.0 114.643 -179.591 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.4 t -41.48 -56.49 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 C-N-CA 126.812 2.045 . . . . 0.0 113.379 177.109 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -140.52 -18.0 0.41 Allowed Glycine 0 N--CA 1.477 1.393 0 C-N-CA 124.244 0.926 . . . . 0.0 115.382 177.821 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 99.1 mt-30 . . . . . 0 CA--C 1.545 0.773 0 C-N-CA 125.821 1.648 . . . . 0.0 113.368 177.103 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 49.3 p-90 . . . . . 0 CA--C 1.546 0.794 0 CA-C-O 121.519 0.676 . . . . 0.0 112.776 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 22.1 mtmt -115.22 -23.78 8.79 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 127.196 2.198 . . . . 0.0 111.252 175.108 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 19.26 -88.76 0.0 OUTLIER 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 131.32 3.848 . . . . 0.0 114.623 -175.142 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 69.1 m-80 -130.28 23.27 5.19 Favored 'General case' 0 CA--C 1.553 1.059 0 C-N-CA 126.933 2.093 . . . . 0.0 111.93 179.294 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 35.3 m -114.93 154.08 47.03 Favored Pre-proline 0 N--CA 1.476 0.837 0 C-N-CA 125.284 1.433 . . . . 0.0 113.251 -169.76 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -78.28 -15.81 14.1 Favored 'Trans proline' 0 CA--C 1.541 0.837 0 C-N-CA 123.311 2.674 . . . . 0.0 112.304 169.288 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 52.25 15.52 0.47 Allowed 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 129.406 3.083 . . . . 0.0 116.38 177.063 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 72.2 26.59 2.72 Favored 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 129.309 3.044 . . . . 0.0 112.715 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 5.3 p -65.75 -25.97 37.7 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.241 0 C-N-CA 124.251 1.02 . . . . 0.0 113.675 -175.091 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 11.2 t . . . . . 0 C--O 1.256 1.419 0 C-N-CA 125.608 1.563 . . . . 0.0 111.63 175.935 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 38.2 pttt . . . . . 0 N--CA 1.481 1.079 0 CA-C-O 119.709 -0.186 . . . . 0.0 111.19 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.437 ' HB2' ' CD1' ' A' ' 10' ' ' TRP . . . -155.79 151.08 26.79 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 126.067 1.747 . . . . 0.0 109.989 169.394 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -71.19 -37.09 63.67 Favored Glycine 0 N--CA 1.478 1.483 0 C-N-CA 123.397 0.522 . . . . 0.0 112.59 179.512 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.5 m -64.75 -32.32 57.51 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.223 0 C-N-CA 124.912 1.285 . . . . 0.0 112.99 169.859 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 133.39 -77.03 0.39 Allowed Glycine 0 N--CA 1.469 0.854 0 C-N-CA 126.576 2.036 . . . . 0.0 111.929 177.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 16.1 mp0 . . . . . 0 CA--C 1.555 1.143 0 C-N-CA 124.918 1.287 . . . . 0.0 112.546 -173.498 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . 0.448 ' CZ3' ' HE3' ' A' ' 11' ' ' LYS . 32.7 p-90 . . . . . 0 CA--C 1.549 0.909 0 CA-C-O 121.619 0.723 . . . . 0.0 112.869 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.448 ' HE3' ' CZ3' ' A' ' 10' ' ' TRP . 14.8 mtmt -46.16 -42.97 14.67 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 127.739 2.416 . . . . 0.0 114.62 -177.638 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 29.89 -99.09 0.01 OUTLIER 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 129.074 2.95 . . . . 0.0 114.134 -170.371 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -162.68 35.3 0.11 Allowed 'General case' 0 CA--C 1.55 0.972 0 C-N-CA 126.642 1.977 . . . . 0.0 111.676 -169.606 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 44.7 m -133.23 152.4 79.41 Favored Pre-proline 0 N--CA 1.478 0.958 0 C-N-CA 124.299 1.04 . . . . 0.0 112.79 -172.528 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -77.94 -16.78 14.14 Favored 'Trans proline' 0 C--N 1.354 0.821 0 C-N-CA 123.556 2.837 . . . . 0.0 112.792 169.783 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 50.62 17.11 0.35 Allowed 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 129.603 3.161 . . . . 0.0 116.54 176.907 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 77.04 32.2 0.49 Allowed 'General case' 0 CA--C 1.551 1.019 0 C-N-CA 129.549 3.14 . . . . 0.0 113.375 174.895 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 42.8 t -56.03 -33.64 36.4 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 C-N-CA 124.513 1.125 . . . . 0.0 112.291 174.26 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 77.5 p . . . . . 0 C--O 1.252 1.233 0 C-N-CA 125.949 1.699 . . . . 0.0 113.372 179.467 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 55.2 tttp . . . . . 0 N--CA 1.476 0.84 0 N-CA-C 112.797 0.666 . . . . 0.0 112.797 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -94.92 -32.31 13.27 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 124.65 1.18 . . . . 0.0 113.481 178.188 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 72.64 19.82 79.33 Favored Glycine 0 CA--C 1.537 1.43 0 C-N-CA 124.127 0.87 . . . . 0.0 114.185 -173.457 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 48.4 t -149.95 -68.64 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 C-N-CA 126.48 1.912 . . . . 0.0 109.21 -172.506 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 158.46 42.21 0.02 OUTLIER Glycine 0 CA--C 1.536 1.353 0 C-N-CA 125.316 1.436 . . . . 0.0 113.41 -178.406 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 40.5 mt-30 . . . . . 0 N--CA 1.479 0.989 0 C-N-CA 126.043 1.737 . . . . 0.0 112.099 -169.751 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . 0.43 ' CZ3' ' HE3' ' A' ' 11' ' ' LYS . 51.0 p-90 . . . . . 0 CA--C 1.545 0.77 0 CA-C-O 120.915 0.388 . . . . 0.0 110.089 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.43 ' HE3' ' CZ3' ' A' ' 10' ' ' TRP . 13.7 mtmt -47.85 -39.99 20.1 Favored 'General case' 0 CA--C 1.552 1.046 0 C-N-CA 126.548 1.939 . . . . 0.0 113.808 178.553 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 19.4 mm-40 46.28 -104.54 0.1 Allowed 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 128.286 2.634 . . . . 0.0 112.016 175.762 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 5.3 p30 -176.88 -48.84 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 127.842 2.457 . . . . 0.0 110.328 174.212 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 21.2 m 71.92 156.82 0.16 Allowed Pre-proline 0 CA--C 1.551 1.019 0 C-N-CA 127.583 2.353 . . . . 0.0 113.744 172.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -76.86 -22.94 11.26 Favored 'Trans proline' 0 C--N 1.354 0.844 0 C-N-CA 122.926 2.417 . . . . 0.0 112.725 170.111 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 50.3 15.87 0.23 Allowed 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 129.496 3.118 . . . . 0.0 116.815 175.379 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 69.78 41.34 1.21 Allowed 'General case' 0 CA--C 1.553 1.065 0 C-N-CA 128.802 2.841 . . . . 0.0 113.083 -178.562 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 42.5 t -58.35 -33.99 49.11 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 C-N-CA 124.053 0.941 . . . . 0.0 112.356 170.337 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 76.2 p . . . . . 0 C--O 1.255 1.365 0 C-N-CA 126.923 2.089 . . . . 0.0 114.828 178.678 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 24.7 mtpp . . . . . 0 N--CA 1.485 1.303 0 N-CA-C 114.31 1.226 . . . . 0.0 114.31 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . 112.22 -36.6 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.303 1 C-N-CA 132.031 4.132 . . . . 0.0 112.541 -179.066 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 73.48 -55.47 2.01 Favored Glycine 0 CA--C 1.532 1.118 0 C-N-CA 126.386 1.946 . . . . 0.0 112.889 -175.092 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 4.8 p -74.78 -38.16 43.83 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.13 0 C-N-CA 125.584 1.554 . . . . 0.0 113.13 -176.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 170.93 -83.47 0.08 OUTLIER Glycine 0 N--CA 1.47 0.921 0 C-N-CA 124.967 1.27 . . . . 0.0 112.803 -175.74 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 6.4 mt-30 . . . . . 0 N--CA 1.48 1.053 0 C-N-CA 129.098 2.959 . . . . 0.0 109.672 -179.7 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 41.9 p-90 . . . . . 0 CA--C 1.544 0.743 0 N-CA-C 112.229 0.455 . . . . 0.0 112.229 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 4.6 mtmt -147.5 23.32 1.14 Allowed 'General case' 0 CA--C 1.557 1.221 0 C-N-CA 127.991 2.516 . . . . 0.0 111.075 -174.668 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -49.73 139.99 12.13 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 124.703 1.201 . . . . 0.0 113.928 -168.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 11.8 p30 -74.0 -18.24 60.88 Favored 'General case' 0 CA--C 1.547 0.841 0 N-CA-C 113.695 0.998 . . . . 0.0 113.695 -178.75 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 21.2 m -72.27 154.33 92.07 Favored Pre-proline 0 CA--C 1.548 0.892 0 C-N-CA 124.864 1.265 . . . . 0.0 112.915 177.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -75.89 -15.48 18.81 Favored 'Trans proline' 0 CA--C 1.541 0.825 0 C-N-CA 123.445 2.763 . . . . 0.0 112.789 169.66 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 51.94 19.89 1.09 Allowed 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 129.241 3.016 . . . . 0.0 116.204 173.491 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . 0.273 12.0 p30 51.29 37.77 19.63 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 129.278 3.031 . . . . 0.0 113.539 -173.241 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 6.9 p -67.77 -26.78 35.89 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.183 0 N-CA-C 113.309 0.855 . . . . 0.0 113.309 -179.611 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 71.0 m . . . . . 0 C--O 1.252 1.228 0 C-N-CA 126.955 2.102 . . . . 0.0 113.13 176.008 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 19.0 pttp . . . . . 0 N--CA 1.484 1.266 0 N-CA-C 113.077 0.769 . . . . 0.0 113.077 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -139.3 -46.19 0.46 Allowed 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 114.449 1.277 . . . . 0.0 114.449 -171.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 77.34 25.08 64.29 Favored Glycine 0 CA--C 1.54 1.614 0 C-N-CA 123.93 0.776 . . . . 0.0 114.212 -173.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.1 m -156.49 -39.41 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 C-N-CA 126.677 1.991 . . . . 0.0 113.153 -172.748 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 118.46 62.05 0.29 Allowed Glycine 0 N--CA 1.474 1.174 0 C-N-CA 125.077 1.322 . . . . 0.0 112.922 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 37.9 mt-30 . . . . . 0 CA--C 1.553 1.077 0 C-N-CA 125.942 1.697 . . . . 0.0 113.707 176.393 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . 0.473 ' CZ3' ' HE3' ' A' ' 11' ' ' LYS . 46.6 p-90 . . . . . 0 CA--C 1.547 0.827 0 CA-C-O 121.22 0.533 . . . . 0.0 111.102 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.473 ' HE3' ' CZ3' ' A' ' 10' ' ' TRP . 15.6 mtmt -43.89 -53.79 5.8 Favored 'General case' 0 CA--C 1.557 1.249 0 C-N-CA 127.001 2.121 . . . . 0.0 113.502 -178.052 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 59.71 -67.72 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 130.131 3.372 . . . . 0.0 115.138 172.088 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 14.5 m-80 72.02 26.29 2.89 Favored 'General case' 0 CA--C 1.55 0.978 0 C-N-CA 126.457 1.903 . . . . 0.0 112.861 173.142 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 16.3 m -61.02 148.25 84.56 Favored Pre-proline 0 CA--C 1.548 0.884 0 C-N-CA 124.929 1.292 . . . . 0.0 114.22 -172.345 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -77.47 -18.06 14.1 Favored 'Trans proline' 0 CA--C 1.541 0.837 0 C-N-CA 123.551 2.834 . . . . 0.0 112.959 170.238 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 51.18 16.61 0.39 Allowed 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 129.407 3.083 . . . . 0.0 116.757 176.076 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 74.84 34.17 0.72 Allowed 'General case' 0 CA--C 1.553 1.068 0 C-N-CA 129.135 2.974 . . . . 0.0 113.013 177.484 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 40.8 t -55.23 -41.13 59.31 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.333 0 C-N-CA 124.094 0.958 . . . . 0.0 111.902 173.225 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 10.7 t . . . . . 0 C--O 1.254 1.333 0 C-N-CA 124.796 1.238 . . . . 0.0 111.63 173.459 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 36.0 tptt . . . . . 0 N--CA 1.479 1.01 0 N-CA-C 112.694 0.627 . . . . 0.0 112.694 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -157.79 124.36 4.88 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 125.829 1.652 . . . . 0.0 111.095 179.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -68.23 -15.77 68.15 Favored Glycine 0 N--CA 1.479 1.509 0 C-N-CA 124.454 1.026 . . . . 0.0 114.759 -175.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 19.8 t -64.77 -22.21 30.9 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 C-N-CA 125.448 1.499 . . . . 0.0 111.897 170.39 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 98.88 31.89 6.12 Favored Glycine 0 CA--C 1.537 1.419 0 C-N-CA 124.746 1.165 . . . . 0.0 113.364 -170.73 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 41.3 mt-30 . . . . . 0 CA--C 1.544 0.746 0 C-N-CA 126.527 1.931 . . . . 0.0 113.133 178.479 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . 0.459 ' CZ3' ' HE3' ' A' ' 11' ' ' LYS . 57.6 p-90 . . . . . 0 CA--C 1.548 0.902 0 N-CA-C 108.447 -0.945 . . . . 0.0 108.447 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.466 ' H ' ' HG3' ' A' ' 11' ' ' LYS . 13.6 mtmt -50.35 -44.66 54.61 Favored 'General case' 0 CA--C 1.554 1.117 0 C-N-CA 125.509 1.523 . . . . 0.0 112.914 176.414 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 16.7 mm-40 58.02 -171.51 0.1 Allowed 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 128.212 2.605 . . . . 0.0 113.285 173.257 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 12.8 p30 -76.53 -16.98 59.49 Favored 'General case' 0 CA--C 1.551 0.989 0 O-C-N 120.998 -1.063 . . . . 0.0 113.267 174.081 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 15.4 m -73.66 157.34 87.68 Favored Pre-proline 0 CA--C 1.546 0.812 0 C-N-CA 125.133 1.373 . . . . 0.0 113.336 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -75.89 -19.19 16.26 Favored 'Trans proline' 0 CA--C 1.541 0.852 0 C-N-CA 122.842 2.362 . . . . 0.0 111.761 169.029 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 55.23 11.92 0.61 Allowed 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 129.311 3.044 . . . . 0.0 116.099 174.807 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 69.37 29.86 4.34 Favored 'General case' 0 CA--C 1.553 1.059 0 C-N-CA 128.775 2.83 . . . . 0.0 112.64 -175.224 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 5.0 p -66.53 -24.45 33.12 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.167 0 N-CA-C 113.789 1.033 . . . . 0.0 113.789 -177.054 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 41.1 m . . . . . 0 C--O 1.254 1.325 0 C-N-CA 125.881 1.672 . . . . 0.0 113.949 -177.782 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 75.8 m . . . . . 0 N--CA 1.494 1.768 0 CA-C-O 119.79 -0.147 . . . . 0.0 111.117 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 9.7 mmm180 60.21 -98.45 0.08 Allowed 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 126.248 1.819 . . . . 0.0 110.72 176.756 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -140.61 20.74 2.36 Favored 'General case' 0 CA--C 1.552 1.03 0 C-N-CA 125.597 1.559 . . . . 0.0 112.406 176.599 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -143.96 102.73 3.93 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.68 1.192 . . . . 0.0 111.926 -174.837 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -70.45 -18.58 75.47 Favored Glycine 0 N--CA 1.477 1.376 0 C-N-CA 124.418 1.009 . . . . 0.0 114.517 -179.324 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.0 t -72.03 -16.28 18.5 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.184 0 C-N-CA 124.882 1.273 . . . . 0.0 112.008 173.758 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 96.34 40.94 3.82 Favored Glycine 0 CA--C 1.534 1.277 0 C-N-CA 124.414 1.007 . . . . 0.0 113.535 -175.526 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 62.17 55.75 2.37 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 125.767 1.627 . . . . 0.0 111.724 -177.49 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . 0.405 ' CE2' ' HG2' ' A' ' 12' ' ' GLU . 30.8 p-90 -156.8 -77.7 0.09 Allowed 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.856 1.662 . . . . 0.0 111.832 -177.068 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 5.3 mtmt -149.97 22.89 0.87 Allowed 'General case' 0 CA--C 1.557 1.222 0 C-N-CA 128.011 2.525 . . . . 0.0 111.1 -176.178 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.405 ' HG2' ' CE2' ' A' ' 10' ' ' TRP . 21.4 mt-10 -52.13 140.95 19.66 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 124.357 1.063 . . . . 0.0 113.485 -169.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 67.9 m-80 -76.84 -25.89 53.7 Favored 'General case' 0 CA--C 1.545 0.758 0 N-CA-C 113.55 0.944 . . . . 0.0 113.55 -173.331 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 27.6 m -73.52 151.85 89.55 Favored Pre-proline 0 CA--C 1.547 0.859 0 C-N-CA 123.92 0.888 . . . . 0.0 112.465 176.656 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -73.77 -18.1 22.34 Favored 'Trans proline' 0 CA--C 1.539 0.766 0 C-N-CA 122.988 2.459 . . . . 0.0 112.703 169.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 53.35 14.17 0.51 Allowed 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 129.67 3.188 . . . . 0.0 116.43 173.443 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 74.32 38.45 0.53 Allowed 'General case' 0 CA--C 1.552 1.055 0 C-N-CA 129.099 2.96 . . . . 0.0 112.908 178.741 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 36.2 t -57.31 -33.73 44.33 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 C-N-CA 124.372 1.069 . . . . 0.0 112.435 172.25 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 10.8 t . . . . . 0 C--O 1.255 1.378 0 C-N-CA 125.144 1.378 . . . . 0.0 113.32 179.809 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 35.9 t . . . . . 0 N--CA 1.491 1.603 0 CA-C-O 119.491 -0.29 . . . . 0.0 110.477 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -164.7 -49.64 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 124.73 1.212 . . . . 0.0 112.912 178.435 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 84.1 mttt 60.78 73.29 0.49 Allowed 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 126.638 1.975 . . . . 0.0 112.66 173.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -62.78 -26.77 68.88 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 125.421 1.488 . . . . 0.0 114.718 -172.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 77.74 -46.12 2.55 Favored Glycine 0 N--CA 1.478 1.455 0 C-N-CA 125.564 1.554 . . . . 0.0 114.031 176.417 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 4.1 m -60.7 -30.52 47.17 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.296 0 C-N-CA 125.032 1.333 . . . . 0.0 114.089 175.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 132.61 24.85 0.73 Allowed Glycine 0 N--CA 1.476 1.336 0 C-N-CA 125.503 1.525 . . . . 0.0 115.63 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 11.8 mt-30 63.41 44.31 5.5 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 125.697 1.599 . . . . 0.0 111.616 -179.291 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 38.3 p-90 -147.74 -79.37 0.15 Allowed 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 126.084 1.754 . . . . 0.0 111.794 179.458 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 6.0 mtmt -151.77 22.53 0.69 Allowed 'General case' 0 CA--C 1.556 1.173 0 C-N-CA 127.746 2.419 . . . . 0.0 111.672 -174.173 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 21.4 mt-10 -51.54 141.03 16.88 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 124.268 1.027 . . . . 0.0 113.753 -169.149 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 68.3 m-80 -81.85 -21.95 37.25 Favored 'General case' 0 CA--C 1.546 0.801 0 N-CA-C 113.625 0.972 . . . . 0.0 113.625 -174.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 22.8 m -71.86 152.76 93.16 Favored Pre-proline 0 N--CA 1.475 0.784 0 O-C-N 121.174 -0.954 . . . . 0.0 112.578 176.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -74.06 -17.59 21.99 Favored 'Trans proline' 0 CA--C 1.539 0.764 0 C-N-CA 123.002 2.468 . . . . 0.0 112.441 169.663 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 53.19 13.92 0.45 Allowed 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 129.664 3.186 . . . . 0.0 116.371 174.428 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 74.79 35.15 0.66 Allowed 'General case' 0 CA--C 1.551 1.013 0 C-N-CA 129.136 2.974 . . . . 0.0 113.121 178.613 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 28.0 t -51.26 -44.06 29.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 C-N-CA 124.474 1.11 . . . . 0.0 111.646 174.057 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 5.6 t . . . . . 0 C--O 1.254 1.313 0 C-N-CA 127.273 2.229 . . . . 0.0 112.887 172.775 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 31.8 p . . . . . 0 N--CA 1.493 1.699 0 N-CA-C 111.442 0.164 . . . . 0.0 111.442 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 27.2 ptt-85 -63.07 143.61 57.63 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 124.007 0.923 . . . . 0.0 113.037 -178.645 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 14.4 tmtt? -168.32 103.95 0.45 Allowed 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 126.674 1.99 . . . . 0.0 110.291 -179.18 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.445 ' HB3' ' H ' ' A' ' 8' ' ' GLN . . . -89.96 139.31 30.73 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 125.173 1.389 . . . . 0.0 111.227 173.658 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -79.13 43.26 2.45 Favored Glycine 0 N--CA 1.476 1.306 0 C-N-CA 125.167 1.365 . . . . 0.0 114.602 -176.078 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 5.6 p -168.83 -50.41 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.262 0 C-N-CA 125.566 1.547 . . . . 0.0 112.657 -177.481 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 145.54 52.6 0.03 OUTLIER Glycine 0 N--CA 1.477 1.392 0 C-N-CA 124.417 1.008 . . . . 0.0 114.906 -178.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.445 ' H ' ' HB3' ' A' ' 4' ' ' ALA . 31.6 mt-30 61.03 42.68 12.29 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 126.049 1.74 . . . . 0.0 112.85 176.212 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 34.3 p-90 -147.49 -80.59 0.14 Allowed 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 125.41 1.484 . . . . 0.0 112.272 -178.695 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 6.8 mtmt -146.91 24.52 1.18 Allowed 'General case' 0 CA--C 1.555 1.17 0 C-N-CA 128.067 2.547 . . . . 0.0 110.877 -175.821 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -54.6 139.0 39.79 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 124.048 0.939 . . . . 0.0 112.497 -169.259 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 9.4 p30 -149.44 17.37 0.92 Allowed 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 124.54 1.136 . . . . 0.0 113.405 -171.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 18.6 m -70.22 154.63 94.4 Favored Pre-proline 0 CA--C 1.549 0.926 0 C-N-CA 125.1 1.36 . . . . 0.0 113.497 -175.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -73.75 -14.66 24.32 Favored 'Trans proline' 0 C--N 1.356 0.922 0 C-N-CA 123.618 2.879 . . . . 0.0 113.372 171.206 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . 0.275 1.8 pp 58.87 4.45 0.4 Allowed 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 130.368 3.467 . . . . 0.0 117.039 169.555 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 29.2 m120 77.5 47.0 0.06 Allowed 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 129.8 3.24 . . . . 0.0 111.789 177.224 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 56.0 t -62.93 -29.57 47.49 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.213 0 C-N-CA 124.361 1.065 . . . . 0.0 111.402 169.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 11.7 p . . . . . 0 C--O 1.253 1.275 0 C-N-CA 126.194 1.798 . . . . 0.0 114.654 175.6 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 47.0 t . . . . . 0 N--CA 1.49 1.574 0 CA-C-O 119.729 -0.177 . . . . 0.0 110.764 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 87.7 mtt-85 -139.16 110.02 6.75 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 125.182 1.393 . . . . 0.0 110.606 171.109 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 54.0 mtmt -112.27 74.05 0.85 Allowed 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 126.428 1.891 . . . . 0.0 108.71 171.288 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -13.97 96.25 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 128.987 2.915 . . . . 0.0 115.244 -169.602 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -67.26 -28.18 73.65 Favored Glycine 0 N--CA 1.479 1.524 0 C-N-CA 123.847 0.737 . . . . 0.0 113.796 -171.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.8 m -61.41 -27.56 42.18 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.158 0 C-N-CA 125.157 1.383 . . . . 0.0 113.286 169.542 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 137.63 123.91 2.24 Favored Glycine 0 CA--C 1.528 0.871 0 C-N-CA 128.011 2.719 . . . . 0.0 109.36 -172.648 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 32.9 mt-30 -72.95 65.67 0.75 Allowed 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 125.293 1.437 . . . . 0.0 111.145 171.677 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . 0.482 ' CZ3' ' HE3' ' A' ' 11' ' ' LYS . 30.2 p-90 -49.35 -64.89 0.67 Allowed 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 126.929 2.092 . . . . 0.0 114.242 179.635 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.482 ' HE3' ' CZ3' ' A' ' 10' ' ' TRP . 27.9 mtmt -145.3 -62.05 0.34 Allowed 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 126.457 1.903 . . . . 0.0 109.034 176.512 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 62.54 171.71 0.14 Allowed 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 128.751 2.82 . . . . 0.0 113.191 178.291 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 69.0 m-80 -112.31 0.87 15.85 Favored 'General case' 0 CA--C 1.549 0.918 0 N-CA-C 114.034 1.124 . . . . 0.0 114.034 -176.244 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 15.8 m -69.76 150.19 96.62 Favored Pre-proline 0 N--CA 1.475 0.823 0 O-C-N 120.712 -1.243 . . . . 0.0 113.614 -175.711 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -76.34 -16.19 17.47 Favored 'Trans proline' 0 CA--C 1.541 0.83 0 C-N-CA 123.33 2.687 . . . . 0.0 112.136 169.383 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 54.17 14.35 0.72 Allowed 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 129.69 3.196 . . . . 0.0 116.498 175.038 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 78.77 33.25 0.27 Allowed 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 129.343 3.057 . . . . 0.0 113.235 172.486 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 47.3 t -56.5 -32.57 36.84 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.381 0 C-N-CA 124.745 1.218 . . . . 0.0 112.251 175.152 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 77.7 p . . . . . 0 C--O 1.253 1.239 0 C-N-CA 125.935 1.694 . . . . 0.0 113.468 179.425 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 80.5 m . . . . . 0 N--CA 1.492 1.66 0 CA-C-O 118.898 -0.572 . . . . 0.0 111.04 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 12.7 ptp180 -153.65 145.4 23.42 Favored 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 125.245 1.418 . . . . 0.0 112.187 178.823 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 4.4 tmtm? -162.9 44.36 0.13 Allowed 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 125.021 1.328 . . . . 0.0 112.209 -173.735 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -169.8 151.75 4.3 Favored 'General case' 0 N--CA 1.481 1.075 0 C-N-CA 127.138 2.175 . . . . 0.0 111.232 -179.368 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -155.1 -46.8 0.02 OUTLIER Glycine 0 N--CA 1.479 1.518 0 C-N-CA 124.984 1.278 . . . . 0.0 114.643 -179.591 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.4 t -41.48 -56.49 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 C-N-CA 126.812 2.045 . . . . 0.0 113.379 177.109 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -140.52 -18.0 0.41 Allowed Glycine 0 N--CA 1.477 1.393 0 C-N-CA 124.244 0.926 . . . . 0.0 115.382 177.821 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 99.1 mt-30 56.43 45.83 21.9 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 125.821 1.648 . . . . 0.0 113.368 177.103 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 49.3 p-90 -76.67 -95.26 0.02 OUTLIER 'General case' 0 CA--C 1.546 0.794 0 O-C-N 121.214 -0.929 . . . . 0.0 112.776 -170.601 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 22.1 mtmt -115.22 -23.78 8.79 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 127.196 2.198 . . . . 0.0 111.252 175.108 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 19.26 -88.76 0.0 OUTLIER 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 131.32 3.848 . . . . 0.0 114.623 -175.142 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 69.1 m-80 -130.28 23.27 5.19 Favored 'General case' 0 CA--C 1.553 1.059 0 C-N-CA 126.933 2.093 . . . . 0.0 111.93 179.294 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 35.3 m -114.93 154.08 47.03 Favored Pre-proline 0 N--CA 1.476 0.837 0 C-N-CA 125.284 1.433 . . . . 0.0 113.251 -169.76 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -78.28 -15.81 14.1 Favored 'Trans proline' 0 CA--C 1.541 0.837 0 C-N-CA 123.311 2.674 . . . . 0.0 112.304 169.288 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 52.25 15.52 0.47 Allowed 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 129.406 3.083 . . . . 0.0 116.38 177.063 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 72.2 26.59 2.72 Favored 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 129.309 3.044 . . . . 0.0 112.715 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 5.3 p -65.75 -25.97 37.7 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.241 0 C-N-CA 124.251 1.02 . . . . 0.0 113.675 -175.091 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 11.2 t . . . . . 0 C--O 1.256 1.419 0 C-N-CA 125.608 1.563 . . . . 0.0 111.63 175.935 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 27.6 p . . . . . 0 N--CA 1.491 1.604 0 CA-C-O 119.596 -0.24 . . . . 0.0 111.616 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 9.3 mtt85 172.03 163.44 0.1 Allowed 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 129.018 2.927 . . . . 0.0 111.555 176.848 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 38.2 pttt -137.07 -68.51 0.48 Allowed 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 125.678 1.591 . . . . 0.0 111.19 178.428 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.437 ' HB2' ' CD1' ' A' ' 10' ' ' TRP . . . -155.79 151.08 26.79 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 126.067 1.747 . . . . 0.0 109.989 169.394 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -71.19 -37.09 63.67 Favored Glycine 0 N--CA 1.478 1.483 0 C-N-CA 123.397 0.522 . . . . 0.0 112.59 179.512 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.5 m -64.75 -32.32 57.51 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.223 0 C-N-CA 124.912 1.285 . . . . 0.0 112.99 169.859 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 133.39 -77.03 0.39 Allowed Glycine 0 N--CA 1.469 0.854 0 C-N-CA 126.576 2.036 . . . . 0.0 111.929 177.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 16.1 mp0 -140.75 14.68 2.31 Favored 'General case' 0 CA--C 1.555 1.143 0 C-N-CA 124.918 1.287 . . . . 0.0 112.546 -173.498 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . 0.448 ' CZ3' ' HE3' ' A' ' 11' ' ' LYS . 32.7 p-90 -161.55 -164.28 1.1 Allowed 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 126.747 2.019 . . . . 0.0 112.869 -178.492 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.448 ' HE3' ' CZ3' ' A' ' 10' ' ' TRP . 14.8 mtmt -46.16 -42.97 14.67 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 127.739 2.416 . . . . 0.0 114.62 -177.638 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 29.89 -99.09 0.01 OUTLIER 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 129.074 2.95 . . . . 0.0 114.134 -170.371 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -162.68 35.3 0.11 Allowed 'General case' 0 CA--C 1.55 0.972 0 C-N-CA 126.642 1.977 . . . . 0.0 111.676 -169.606 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 44.7 m -133.23 152.4 79.41 Favored Pre-proline 0 N--CA 1.478 0.958 0 C-N-CA 124.299 1.04 . . . . 0.0 112.79 -172.528 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -77.94 -16.78 14.14 Favored 'Trans proline' 0 C--N 1.354 0.821 0 C-N-CA 123.556 2.837 . . . . 0.0 112.792 169.783 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 50.62 17.11 0.35 Allowed 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 129.603 3.161 . . . . 0.0 116.54 176.907 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 77.04 32.2 0.49 Allowed 'General case' 0 CA--C 1.551 1.019 0 C-N-CA 129.549 3.14 . . . . 0.0 113.375 174.895 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 42.8 t -56.03 -33.64 36.4 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 C-N-CA 124.513 1.125 . . . . 0.0 112.291 174.26 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 77.5 p . . . . . 0 C--O 1.252 1.233 0 C-N-CA 125.949 1.699 . . . . 0.0 113.372 179.467 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 78.3 m . . . . . 0 N--CA 1.493 1.698 0 CA-C-O 119.739 -0.172 . . . . 0.0 111.207 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 57.4 mtm180 54.23 41.24 32.09 Favored 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 125.801 1.64 . . . . 0.0 113.719 174.759 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 55.2 tttp -78.67 -52.86 7.83 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 124.364 1.066 . . . . 0.0 112.797 -173.641 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -94.92 -32.31 13.27 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 124.65 1.18 . . . . 0.0 113.481 178.188 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 72.64 19.82 79.33 Favored Glycine 0 CA--C 1.537 1.43 0 C-N-CA 124.127 0.87 . . . . 0.0 114.185 -173.457 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 48.4 t -149.95 -68.64 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 C-N-CA 126.48 1.912 . . . . 0.0 109.21 -172.506 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 158.46 42.21 0.02 OUTLIER Glycine 0 CA--C 1.536 1.353 0 C-N-CA 125.316 1.436 . . . . 0.0 113.41 -178.406 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 40.5 mt-30 55.8 39.21 30.73 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 126.043 1.737 . . . . 0.0 112.099 -169.751 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . 0.43 ' CZ3' ' HE3' ' A' ' 11' ' ' LYS . 51.0 p-90 -165.9 -156.6 0.27 Allowed 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 128.29 2.636 . . . . 0.0 110.089 176.529 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.43 ' HE3' ' CZ3' ' A' ' 10' ' ' TRP . 13.7 mtmt -47.85 -39.99 20.1 Favored 'General case' 0 CA--C 1.552 1.046 0 C-N-CA 126.548 1.939 . . . . 0.0 113.808 178.553 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 19.4 mm-40 46.28 -104.54 0.1 Allowed 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 128.286 2.634 . . . . 0.0 112.016 175.762 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 5.3 p30 -176.88 -48.84 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 127.842 2.457 . . . . 0.0 110.328 174.212 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 21.2 m 71.92 156.82 0.16 Allowed Pre-proline 0 CA--C 1.551 1.019 0 C-N-CA 127.583 2.353 . . . . 0.0 113.744 172.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -76.86 -22.94 11.26 Favored 'Trans proline' 0 C--N 1.354 0.844 0 C-N-CA 122.926 2.417 . . . . 0.0 112.725 170.111 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 50.3 15.87 0.23 Allowed 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 129.496 3.118 . . . . 0.0 116.815 175.379 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 69.78 41.34 1.21 Allowed 'General case' 0 CA--C 1.553 1.065 0 C-N-CA 128.802 2.841 . . . . 0.0 113.083 -178.562 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 42.5 t -58.35 -33.99 49.11 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 C-N-CA 124.053 0.941 . . . . 0.0 112.356 170.337 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 76.2 p . . . . . 0 C--O 1.255 1.365 0 C-N-CA 126.923 2.089 . . . . 0.0 114.828 178.678 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 7.7 p . . . . . 0 N--CA 1.494 1.752 0 CA-C-O 121.143 0.497 . . . . 0.0 111.885 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.9 99.29 11.1 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 124.704 1.201 . . . . 0.0 110.818 -176.792 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 24.7 mtpp 48.79 37.86 10.69 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 126.263 1.825 . . . . 0.0 114.31 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . 112.22 -36.6 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.303 1 C-N-CA 132.031 4.132 . . . . 0.0 112.541 -179.066 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 73.48 -55.47 2.01 Favored Glycine 0 CA--C 1.532 1.118 0 C-N-CA 126.386 1.946 . . . . 0.0 112.889 -175.092 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 4.8 p -74.78 -38.16 43.83 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.13 0 C-N-CA 125.584 1.554 . . . . 0.0 113.13 -176.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 170.93 -83.47 0.08 OUTLIER Glycine 0 N--CA 1.47 0.921 0 C-N-CA 124.967 1.27 . . . . 0.0 112.803 -175.74 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 6.4 mt-30 -177.86 53.59 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 129.098 2.959 . . . . 0.0 109.672 -179.7 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 41.9 p-90 -151.54 -83.71 0.09 Allowed 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 125.565 1.546 . . . . 0.0 112.229 -175.026 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 4.6 mtmt -147.5 23.32 1.14 Allowed 'General case' 0 CA--C 1.557 1.221 0 C-N-CA 127.991 2.516 . . . . 0.0 111.075 -174.668 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -49.73 139.99 12.13 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 124.703 1.201 . . . . 0.0 113.928 -168.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 11.8 p30 -74.0 -18.24 60.88 Favored 'General case' 0 CA--C 1.547 0.841 0 N-CA-C 113.695 0.998 . . . . 0.0 113.695 -178.75 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 21.2 m -72.27 154.33 92.07 Favored Pre-proline 0 CA--C 1.548 0.892 0 C-N-CA 124.864 1.265 . . . . 0.0 112.915 177.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -75.89 -15.48 18.81 Favored 'Trans proline' 0 CA--C 1.541 0.825 0 C-N-CA 123.445 2.763 . . . . 0.0 112.789 169.66 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 51.94 19.89 1.09 Allowed 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 129.241 3.016 . . . . 0.0 116.204 173.491 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . 0.273 12.0 p30 51.29 37.77 19.63 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 129.278 3.031 . . . . 0.0 113.539 -173.241 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 6.9 p -67.77 -26.78 35.89 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.183 0 N-CA-C 113.309 0.855 . . . . 0.0 113.309 -179.611 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 71.0 m . . . . . 0 C--O 1.252 1.228 0 C-N-CA 126.955 2.102 . . . . 0.0 113.13 176.008 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 85.6 m . . . . . 0 N--CA 1.493 1.703 0 CA-C-O 118.932 -0.556 . . . . 0.0 112.209 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -75.59 124.3 26.98 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 124.981 1.312 . . . . 0.0 113.022 -174.4 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 19.0 pttp -167.2 34.1 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 126.799 2.04 . . . . 0.0 113.077 -175.793 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -139.3 -46.19 0.46 Allowed 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 114.449 1.277 . . . . 0.0 114.449 -171.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 77.34 25.08 64.29 Favored Glycine 0 CA--C 1.54 1.614 0 C-N-CA 123.93 0.776 . . . . 0.0 114.212 -173.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.1 m -156.49 -39.41 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 C-N-CA 126.677 1.991 . . . . 0.0 113.153 -172.748 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 118.46 62.05 0.29 Allowed Glycine 0 N--CA 1.474 1.174 0 C-N-CA 125.077 1.322 . . . . 0.0 112.922 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 37.9 mt-30 62.19 33.86 16.52 Favored 'General case' 0 CA--C 1.553 1.077 0 C-N-CA 125.942 1.697 . . . . 0.0 113.707 176.393 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . 0.473 ' CZ3' ' HE3' ' A' ' 11' ' ' LYS . 46.6 p-90 -163.08 -162.25 0.75 Allowed 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 127.641 2.376 . . . . 0.0 111.102 176.075 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.473 ' HE3' ' CZ3' ' A' ' 10' ' ' TRP . 15.6 mtmt -43.89 -53.79 5.8 Favored 'General case' 0 CA--C 1.557 1.249 0 C-N-CA 127.001 2.121 . . . . 0.0 113.502 -178.052 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 59.71 -67.72 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 130.131 3.372 . . . . 0.0 115.138 172.088 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 14.5 m-80 72.02 26.29 2.89 Favored 'General case' 0 CA--C 1.55 0.978 0 C-N-CA 126.457 1.903 . . . . 0.0 112.861 173.142 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 16.3 m -61.02 148.25 84.56 Favored Pre-proline 0 CA--C 1.548 0.884 0 C-N-CA 124.929 1.292 . . . . 0.0 114.22 -172.345 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -77.47 -18.06 14.1 Favored 'Trans proline' 0 CA--C 1.541 0.837 0 C-N-CA 123.551 2.834 . . . . 0.0 112.959 170.238 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 51.18 16.61 0.39 Allowed 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 129.407 3.083 . . . . 0.0 116.757 176.076 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 74.84 34.17 0.72 Allowed 'General case' 0 CA--C 1.553 1.068 0 C-N-CA 129.135 2.974 . . . . 0.0 113.013 177.484 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 40.8 t -55.23 -41.13 59.31 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.333 0 C-N-CA 124.094 0.958 . . . . 0.0 111.902 173.225 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 10.7 t . . . . . 0 C--O 1.254 1.333 0 C-N-CA 124.796 1.238 . . . . 0.0 111.63 173.459 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 87.7 m . . . . . 0 N--CA 1.492 1.63 0 CA-C-O 119.064 -0.494 . . . . 0.0 111.907 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 4.2 ppt_? -60.16 138.58 57.88 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 124.127 0.971 . . . . 0.0 113.556 -174.338 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 36.0 tptt -168.34 -45.78 0.02 OUTLIER 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 125.662 1.585 . . . . 0.0 112.694 179.616 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -157.79 124.36 4.88 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 125.829 1.652 . . . . 0.0 111.095 179.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -68.23 -15.77 68.15 Favored Glycine 0 N--CA 1.479 1.509 0 C-N-CA 124.454 1.026 . . . . 0.0 114.759 -175.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 19.8 t -64.77 -22.21 30.9 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 C-N-CA 125.448 1.499 . . . . 0.0 111.897 170.39 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 98.88 31.89 6.12 Favored Glycine 0 CA--C 1.537 1.419 0 C-N-CA 124.746 1.165 . . . . 0.0 113.364 -170.73 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 41.3 mt-30 66.48 60.81 0.58 Allowed 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 126.527 1.931 . . . . 0.0 113.133 178.479 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' SEP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . 0.459 ' CZ3' ' HE3' ' A' ' 11' ' ' LYS . 57.6 p-90 -169.33 -153.43 0.11 Allowed 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 130.028 3.331 . . . . 0.0 108.447 178.865 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.466 ' H ' ' HG3' ' A' ' 11' ' ' LYS . 13.6 mtmt -50.35 -44.66 54.61 Favored 'General case' 0 CA--C 1.554 1.117 0 C-N-CA 125.509 1.523 . . . . 0.0 112.914 176.414 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 16.7 mm-40 58.02 -171.51 0.1 Allowed 'General case' 0 CA--C 1.55 0.962 0 C-N-CA 128.212 2.605 . . . . 0.0 113.285 173.257 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 12.8 p30 -76.53 -16.98 59.49 Favored 'General case' 0 CA--C 1.551 0.989 0 O-C-N 120.998 -1.063 . . . . 0.0 113.267 174.081 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 15.4 m -73.66 157.34 87.68 Favored Pre-proline 0 CA--C 1.546 0.812 0 C-N-CA 125.133 1.373 . . . . 0.0 113.336 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -75.89 -19.19 16.26 Favored 'Trans proline' 0 CA--C 1.541 0.852 0 C-N-CA 122.842 2.362 . . . . 0.0 111.761 169.029 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 55.23 11.92 0.61 Allowed 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 129.311 3.044 . . . . 0.0 116.099 174.807 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 69.37 29.86 4.34 Favored 'General case' 0 CA--C 1.553 1.059 0 C-N-CA 128.775 2.83 . . . . 0.0 112.64 -175.224 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 5.0 p -66.53 -24.45 33.12 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.167 0 N-CA-C 113.789 1.033 . . . . 0.0 113.789 -177.054 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 41.1 m . . . . . 0 C--O 1.254 1.325 0 C-N-CA 125.881 1.672 . . . . 0.0 113.949 -177.782 . . . . . . . . 0 0 . 1 stop_ save_